MSK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | T487 | Sugiyama | SHTN1 KIAA1598 | sLDPENsEtELERILRRRKVtAEADsssPtGILAtsEsKsM |
| A1L170 | S258 | Sugiyama | C1orf226 | PIsLAEsWEDGsPPPQARtssLDNEGPHPDLLsFE______ |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| O00273 | S28 | Sugiyama | DFFA DFF1 DFF45 H13 | GVPESGEIRTLKPCLLRRNysREQHGVAAsCLEDLRSKACD |
| O00512 | S104 | Sugiyama | BCL9 | GLKNGAGNGAKGKGKRERsIsADsFDQRDPGtPNDDsDIKE |
| O14579 | S99 | Sugiyama | COPE | PELQAVRMFADyLAHEsRRDsIVAELDREMsRSVDVTNTTF |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14974 | S894 | Sugiyama | PPP1R12A MBS MYPT1 | EEGsNKKEtQtDsIsRyETssTsAGDRyDsLLGRsGsysYL |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15357 | S1176 | Sugiyama | INPPL1 SHIP2 | RGLPsDyGRPLsFPPPRIREsIQEDLAEEAPCLQGGRASGL |
| O15372 | S290 | Sugiyama | EIF3H EIF3S3 | QQQQKHQYQQRRQQENMQRQsRGEPPLPEEDLsKLFKPPQP |
| O15446 | T433 | Sugiyama | POLR1G ASE1 CAST CD3EAP PAF49 | EPQAAPtstKKKKKKKERGHtVtEPIQPLEPELPGEGQPEA |
| O43615 | S180 | Sugiyama | TIMM44 MIMT44 TIM44 | AESVSKGGEKLGRTAAFRALsQGVEsVKKEIDDsVLGQtGP |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60279 | S70 | Sugiyama | SUSD5 KIAA0527 | QGLQLEAARLSCKSRGAHLAsADELRRVVQDCSFAVCTTGW |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | S486 | Sugiyama | TBC1D4 AS160 KIAA0603 | ERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPVS |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60343 | S751 | Sugiyama | TBC1D4 AS160 KIAA0603 | EIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRRIS |
| O60664 | S93 | Sugiyama | PLIN3 M6PRBP1 TIP47 | AAVsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQP |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60927 | S74 | Sugiyama | PPP1R11 HCGV TCTE5 | GRRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGH |
| O75122 | S616 | Sugiyama | CLASP2 KIAA0627 | sDVEEAVADALKKPARRRyEsYGMHsDDDANSDASSACSER |
| O75128 | S962 | Sugiyama | COBL KIAA0633 | EDLAVGAPPRGEVIGPHRKLstQDRPAAIHRssCFSLVQSS |
| O75348 | S68 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | RLQREKEFKAKEAAALGsRGsCstEVEKETQEKMTILQtyF |
| O75369 | S1442 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | SKVKIAGPGLGsGVRARVLQsFtVDSSKAGLAPLEVRVLGP |
| O75400 | T948 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | GNWDtsGsELsEGELEKRRRtLLEQLDDDQ___________ |
| O75534 | T582 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | VEYSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVI |
| O75582 | S212 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KA5 MSK1 | VLTDFGLSKEFVADETERAYsFCGtIEYMAPDIVRGGDSGH |
| O75582 | S376 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KA5 MSK1 | DPtYsPAALPQssEKLFQGYsFVAPsILFKRNAAVIDPLQF |
| O75582 | S381 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KA5 MSK1 | PAALPQssEKLFQGYsFVAPsILFKRNAAVIDPLQFHMGVE |
| O75582 | S436 | Sugiyama | RPS6KA5 MSK1 | DSPFYQHYDLDLKDKPLGEGsFSICRKCVHKKSNQAFAVKI |
| O75582 | S517 | Sugiyama | RPS6KA5 MSK1 | VMELLNGGELFERIKKKKHFsETEASYIMRKLVSAVSHMHD |
| O75582 | S633 | Sugiyama | RPS6KA5 MSK1 | YTMLSGQVPFQSHDRsLtCTsAVEIMKKIKKGDFsFEGEAW |
| O75582 | S647 | Sugiyama | RPS6KA5 MSK1 | RsLtCTsAVEIMKKIKKGDFsFEGEAWKNVSQEAKDLIQGL |
| O75582 | S750 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KA5 MSK1 | FCLQNVDKAPLAKRRKMKKTsTsTETRssssESSHSSSsHS |
| O75582 | S752 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KA5 MSK1 | LQNVDKAPLAKRRKMKKTsTsTETRssssESSHSSSsHSHG |
| O75582 | S758 | GPS6|SIGNOR|ELM|EPSD|PSP | RPS6KA5 MSK1 | APLAKRRKMKKTsTsTETRssssESSHSSSsHSHGKTTPTK |
| O75582 | S788 | Sugiyama | RPS6KA5 MSK1 | sHSHGKTTPTKTLQPSNPADsNNPEtLFQFSDsVA______ |
| O75582 | S800 | Sugiyama | RPS6KA5 MSK1 | LQPSNPADsNNPEtLFQFSDsVA__________________ |
| O75582 | T216 | Sugiyama | RPS6KA5 MSK1 | FGLSKEFVADETERAYsFCGtIEYMAPDIVRGGDSGHDKAV |
| O75582 | T34 | Sugiyama | RPS6KA5 MSK1 | tsADGGDGGEQLLTVKHELRtANLtGHAEKVGIENFELLKV |
| O75582 | T38 | Sugiyama | RPS6KA5 MSK1 | GGDGGEQLLTVKHELRtANLtGHAEKVGIENFELLKVLGTG |
| O75582 | T630 | Sugiyama | RPS6KA5 MSK1 | VILYTMLSGQVPFQSHDRsLtCTsAVEIMKKIKKGDFsFEG |
| O75582 | T718 | Sugiyama | RPS6KA5 MSK1 | LMtPDILGSSGAAVHTCVKAtFHAFNKYKREGFCLQNVDKA |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O76021 | S317 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | EKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPESKK |
| O94761 | S27 | Sugiyama | RECQL4 RECQ4 | VRERLQAWERAFRRQRGRRPsQDDVEAAPEETRALYREYRT |
| O94888 | S280 | Sugiyama | UBXN7 KIAA0794 UBXD7 | EHGQLDGLsssPPKKCARsEsLIDAsEDsQLEAAIRASLQE |
| O94992 | S268 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | EDGGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELI |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95155 | S79 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | NMtPAtsPIGASGVAHRsQssEGVssLsssPsNsLEtQsQs |
| O95602 | T1373 | Sugiyama | POLR1A | SIKKKNNKASAFRNVNTRRAtQRDLDNAGELGRSRGEQEGD |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| O95757 | S586 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | DRLNQTLKKGKVKsIDLPIQssLCRQLGQDLLNsyIENEGK |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S458 | Sugiyama | LMNA LMN1 | GRVAVEEVDEEGKFVRLRNKsNEDQsMGNWQIKRQNGDDPL |
| P04040 | S254 | Sugiyama | CAT | FHYKTDQGIKNLSVEDAARLsQEDPDYGIRDLFNAIATGKY |
| P04040 | T434 | Sugiyama | CAT | QQPSALEHSIQYSGEVRRFNtANDDNVtQVRAFyVNVLNEE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04792 | S78 | Sugiyama | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05114 | S21 | GPS6|EPSD | HMGN1 HMG14 | MPKRKVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAA |
| P05114 | S25 | GPS6|EPSD | HMGN1 HMG14 | KVssAEGAAKEEPKRRsARLsAKPPAKVEAKPKKAAAKDKS |
| P05114 | S7 | SIGNOR|iPTMNet|EPSD | HMGN1 HMG14 | ______________MPKRKVssAEGAAKEEPKRRsARLsAK |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S177 | Sugiyama | KRT18 CYK18 PIG46 | ARLAADDFRVKyETELAMRQsVENDIHGLRKVIDDTNItRL |
| P05783 | S93 | Sugiyama | KRT18 CYK18 PIG46 | GMGGIQNEKETMQsLNDRLAsyLDRVRSLETENRRLESKIR |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | S291 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKFtAsA |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P06899 | S39 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P07101 | S40 | SIGNOR|iPTMNet|EPSD | TH TYH | ELDAKQAEAIMVRGQGAPGPsLTGsPWPGTAAPAASYTPTP |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07602 | S29 | Sugiyama | PSAP GLBA SAP1 | SLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVKHCL |
| P07602 | T26 | Sugiyama | PSAP GLBA SAP1 | LLASLLGAALAGPVLGLKECtRGsAVWCQNVKTASDCGAVK |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07737 | T65 | Sugiyama | PFN1 | PAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQDGEFs |
| P07737 | Y60 | Sugiyama | PFN1 | FVNITPAEVGVLVGKDRssFyVNGLtLGGQKCsVIRDsLLQ |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P0C0S8 | S2 | GPS6|SIGNOR|ELM|EPSD | H2AC11 H2AFP HIST1H2AG; H2AC13 H2AFC HIST1H2AI; H2AC15 H2AFD HIST1H2AK; H2AC16 H2AFI HIST1H2AL; H2AC17 H2AFN HIST1H2AM | ___________________MsGRGKQGGKARAKAKTRssRA |
| P0CAP2 | T184 | Sugiyama | POLR2M GRINL1A | PSSEASEHHPRHRVssQAEDtSssFDNLFIDRLQRITIADQ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10276 | S369 | EPSD|PSP | RARA NR1B1 | DMLQEPLLEALKVYVRKRRPsRPHMFPKMLMKITDLRSISA |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P11216 | S430 | Sugiyama | PYGB | RHLDHVAALFPGDVDRLRRMsVIEEGDCKRINMAHLCVIGS |
| P11274 | S371 | Sugiyama | BCR BCR1 D22S11 | SRVsPsPTTyRMFRDKsRsPsQNsQQsFDSssPPtPQCHKR |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P11831 | S103 | EPSD|PSP | SRF | sEsGEEEELGAERRGLKRsLsEMEIGMVVGGPEASAAATGG |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P12268 | S416 | Sugiyama | IMPDH2 IMPD2 | APGEYFFSDGIRLKKyRGMGsLDAMDKHLssQNRyFsEADK |
| P12270 | S135 | Sugiyama | TPR | RTKEELEAEKRDLIRTNERLsQELEyLTEDVKRLNEKLKES |
| P12270 | S2155 | Sugiyama | TPR | PstPtLVVPHRtDGFAEAIHsPQVAGVPRFRFGPPEDMPQT |
| P12956 | S477 | Sugiyama | XRCC6 G22P1 | EQVGKMKAIVEKLRFtYRsDsFENPVLQQHFRNLEALALDL |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13667 | S126 | Sugiyama | PDIA4 ERP70 ERP72 | NILKDKDPPIPVAKIDAtsAsVLAsRFDVsGyPtIKILKKG |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14618 | T95 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTK |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S746 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GyLLPDTKAYGDRIERMLRLsLNIDPDAKVEEEPEEEPEET |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15336 | S62 | Sugiyama | ATF2 CREB2 CREBP1 | LAVHKHKHEMtLKFGPARNDsVIVADQtPtPtRFLKNCEEV |
| P15374 | S126 | Sugiyama | UCHL3 | NNKDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRV |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16220 | S119 | SIGNOR|PSP | CREB1 | EsVDsVTDsQKRREILsRRPsYRKILNDLssDAPGVPRIEE |
| P16333 | S85 | Sugiyama | NCK1 NCK | ASIVKNLKDTLGIGKVKRKPsVPDsAsPADDsFVDPGERLy |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16949 | S63 | Sugiyama | STMN1 C1orf215 LAP18 OP18 | KDLsLEEIQKKLEAAEERRKsHEAEVLKQLAEKREHEKEVL |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P18583 | S2009 | Sugiyama | SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 | SRRSRTPSRRRRSRSVVRRRsFsIsPVRLRRSRTPLRRRFs |
| P18583 | S2013 | Sugiyama | SON C21orf50 DBP5 KIAA1019 NREBP HSPC310 HSPC312 | RTPSRRRRSRSVVRRRsFsIsPVRLRRSRTPLRRRFsRsPI |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18846 | S63 | SIGNOR|iPTMNet|EPSD|PSP | ATF1 | DsSDsIGssQKAHGILARRPsYRKILKDLsSEDTRGRKGDG |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S458 | Sugiyama | NCL | TEADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKN |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19419 | S383 | SIGNOR|EPSD|PSP | ELK1 | tPVLLtPSSLPPSIHFWSTLsPIAPRsPAKLSFQFPSSGSA |
| P20290 | S173 | Sugiyama | BTF3 NACB OK/SW-cl.8 | QLGADsLtsLRRLAEALPKQsVDGKAPLAtGEDDDDEVPDL |
| P20810 | S366 | Sugiyama | CAST | DKDGKPLLPEPEEKPKPRsEsELIDELsEDFDRsECKEKPS |
| P20810 | S411 | Sugiyama | CAST | KTEESKAAAPAPVSEAVCRtsMCsIQSAPPEPATLKGTVPD |
| P22033 | S481 | Sugiyama | MMUT MUT | EGIPKLRIEECAARRQARIDsGSEVIVGVNKYQLEKEDAVE |
| P22087 | S124 | Sugiyama | FBL FIB1 FLRN | DALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWNPFRSKL |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22736 | S351 | SIGNOR|iPTMNet|EPSD | NR4A1 GFRP1 HMR NAK1 | GMVKEVVRTDsLKGRRGRLPsKPKQPPDAsPANLLtSLVRA |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P23527 | S39 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKA |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | S597 | Sugiyama | EIF4B | KKPEENPASKFssASKyAALsVDGEDENEGEDyAE______ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25054 | S2129 | Sugiyama | APC DP2.5 | NSIVSSLHQAAAAACLsRQAssDSDSILSLKsGIsLGsPFH |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25705 | S65 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | KtGtAEMssILEERILGADtsVDLEETGRVLsIGDGIARVH |
| P25789 | S7 | Sugiyama | PSMA4 HC9 PSC9 | ______________MSRRyDsRttIFsPEGRLYQVEYAMEA |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P25789 | Y5 | Sugiyama | PSMA4 HC9 PSC9 | ________________MSRRyDsRttIFsPEGRLYQVEYAM |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27448 | S42 | Sugiyama | MARK3 CTAK1 EMK2 | GDGRQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTI |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S86 | Sugiyama | EEF1D EF1D | GPGAssGtsGDHGELVVRIAsLEVENQsLRGVVQELQQAIs |
| P30043 | T190 | Sugiyama | BLVRB FLR SCAN | RGPSRVISKHDLGHFMLRCLttDEyDGHstyPsHQyQ____ |
| P30048 | S86 | Sugiyama | PRDX3 AOP1 | TQHAPYFKGTAVVNGEFKDLsLDDFKGKYLVLFFYPLDFTF |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | S54 | Sugiyama | PEBP1 PBP PEBP | VDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAP |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30533 | S247 | Sugiyama | LRPAP1 A2MRAP | KLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSA |
| P30533 | Y246 | Sugiyama | LRPAP1 A2MRAP | EKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQS |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P33176 | S663 | Sugiyama | KIF5B KNS KNS1 | IKSLtEyLQNVEQKKRQLEEsVDALSEELVQLRAQEKVHEM |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33316 | S130 | Sugiyama | DUT | GGMQLRFARLsEHAtAPTRGsARAAGYDLYSAYDYTIPPME |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P33778 | S39 | Sugiyama | H2BC3 H2BFF HIST1H2BB | ITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35269 | T156 | Sugiyama | GTF2F1 RAP74 | EAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHFSI |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40763 | S727 | GPS6|SIGNOR|EPSD | STAT3 APRF | KTKFICVtPttCsNtIDLPMsPRTLDSLMQFGNNGEGAEPS |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P42224 | S727 | EPSD | STAT1 | IsVsEVHPSRLQttDNLLPMsPEEFDEVSRIVGsVEFDSMM |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P43121 | S93 | Sugiyama | MCAM MUC18 | IFRVRQGQGQSEPGEYEQRLsLQDRGAtLALtQVtPQDERI |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43243 | T150 | Sugiyama | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S727 | SIGNOR|iPTMNet|EPSD|Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48637 | S276 | Sugiyama | GSS | VDGQEIAVVYFRDGYMPRQYsLQNWEARLLLERSHAAKCPD |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49792 | T3217 | Sugiyama | RANBP2 NUP358 | DTVKKIESFGsPKGSVCRRItITECGQI_____________ |
| P49815 | T1462 | Sugiyama | TSC2 TSC4 | EGPLPsssPRsPsGLRPRGYtIsDsAPsRRGKRVERDALKS |
| P49840 | S21 | Sugiyama | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50454 | S139 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | SNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHS |
| P50454 | S141 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | STARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEHSKI |
| P50549 | S191 | GPS6|iPTMNet|EPSD | ETV1 ER81 | PSQSIPDSSYPMDHRFRRQLsEPCNSFPPLPTMPREGRPMY |
| P50549 | S216 | GPS6|SIGNOR|iPTMNet|EPSD | ETV1 ER81 | SFPPLPTMPREGRPMYQRQMsEPNIPFPPQGFKQEYHDPVY |
| P50549 | S334 | iPTMNet|EPSD | ETV1 ER81 | GDIKQEPGMYREGPTYQRRGsLQLWQFLVALLDDPSNSHFI |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P51116 | S504 | Sugiyama | FXR2 FMR1L2 | PTGGRGRGPPPAPRPTSRYNsSsISSVLKDPDsNPYSLLDt |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T598 | Sugiyama | FXR2 FMR1L2 | DESRPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRA |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52597 | S265 | Sugiyama | HNRNPF HNRPF | EySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQs |
| P52907 | S119 | Sugiyama | CAPZA1 | DHLRKEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNG |
| P52907 | S123 | Sugiyama | CAPZA1 | KEAsDPQPEEADGGLKsWREsCDsALRAYVKDHYSNGFCTV |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54253 | S775 | EPSD|PSP | ATXN1 ATX1 SCA1 | APFLTKIEPSKPAATRKRRWsAPESRKLEKSEDEPPLTLPK |
| P55196 | S1774 | Sugiyama | AFDN AF6 MLLT4 | TGAAVGAHDACRDAKEKRsKsQDADsPGssGAPENLTFKER |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P57721 | T159 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | sQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAVT |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60468 | S49 | Sugiyama | SEC61B | STVRQRKNASCGTRSAGRtTsAGTGGMWRFYTEDSPGLKVG |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60983 | T27 | Sugiyama | GMFB | VCDVAEDLVEKLRKFRFRKEtNNAAIIMKIDKDKRLVVLDE |
| P61081 | S175 | Sugiyama | UBE2M UBC12 | NNRRLFEQNVQRSMRGGyIGstyFERCLK____________ |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62195 | S120 | Sugiyama | PSMC5 SUG1 | DKNIDINDVtPNCRVALRNDsytLHKILPNKVDPLVSLMMV |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62304 | S89 | Sugiyama | SNRPE | KSRKQLGRIMLKGDNITLLQsVsN_________________ |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63220 | S31 | Sugiyama | RPS21 | LYVPRKCSASNRIIGAKDHAsIQMNVAEVDKVTGRFNGQFK |
| P63220 | S65 | Sugiyama | RPS21 | RFNGQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF__ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68431 | S11 | GPS6|SIGNOR|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | __________MARtKQtARKstGGKAPRKQLATKAARKsAP |
| P68431 | S29 | GPS6|SIGNOR|EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84243 | S11 | GPS6|SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | __________MARtKQTARKstGGKAPRKQLATKAARKsAP |
| P84243 | S29 | GPS6|SIGNOR | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | RKstGGKAPRKQLATKAARKsAPsTGGVKKPHRyRPGtVAL |
| Q00537 | S137 | Sugiyama | CDK17 PCTAIRE2 PCTK2 | SDEVQsPtGVCLRNRIHRRIsMEDLNKRLsLPADIRIPDGY |
| Q00587 | S192 | Sugiyama | CDC42EP1 BORG5 CEP1 MSE55 | PHDRDRDGsFPsEPGLRRsDsLLsFRLDLDLGPSLLSELLG |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q01650 | S31 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | LAAPAAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNIT |
| Q01650 | S35 | Sugiyama | SLC7A5 CD98LC LAT1 MPE16 | AAEEKEEAREKMLAAKsADGsAPAGEGEGVtLQRNITLLNG |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q02818 | S369 | Sugiyama | NUCB1 NUC | RFEEELAAREAELNAKAQRLsQETEALGRsQGRLEAQKREL |
| Q04206 | S276 | GPS6|SIGNOR|ELM|EPSD|PSP | RELA NFKB3 | PYADPsLQAPVRVsMQLRRPsDRELsEPMEFQYLPDTDDRH |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q07020 | T85 | Sugiyama | RPL18 | RMIRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRV |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08211 | S452 | Sugiyama | DHX9 DDX9 LKP NDH2 | NDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSCGYS |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q12770 | S822 | Sugiyama | SCAP KIAA0199 PSEC0227 | DAQTGDCLTRIPRPGRQRRDsGVGsGLEAQEsWERLsDGGK |
| Q12802 | S1507 | Sugiyama | AKAP13 BRX HT31 LBC | HGsDVSLSQILKPNRSRDRQsLDGFysHGMGAEGRESESEP |
| Q12965 | S1002 | Sugiyama | MYO1E MYO1C | RSNQKSLyTsMARPPLPRQQstssDRVsQtPEsLDFLKVPD |
| Q12965 | T936 | Sugiyama | MYO1E MYO1C | LQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAAP |
| Q13017 | S1195 | Sugiyama | ARHGAP5 RHOGAP5 | AsDDEAFttSKTKRKGRHRGsEEDPLLsPVETWKGGIDNPA |
| Q13185 | S93 | PSP | CBX3 | IEAFLNSQKAGKEKDGtKRKsLsDsEsDDsKSKKKRDAADK |
| Q13247 | S299 | Sugiyama | SRSF6 SFRS6 SRP55 | RSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPP |
| Q13247 | S301 | Sugiyama | SRSF6 SFRS6 SRP55 | PKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKR |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S253 | Sugiyama | G3BP1 G3BP | PAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPH |
| Q13428 | S996 | Sugiyama | TCOF1 | AQAQAAstPRKARASESTARssssEsEDEDVIPAtQCLtPG |
| Q13428 | S999 | Sugiyama | TCOF1 | QAAstPRKARASESTARssssEsEDEDVIPAtQCLtPGIRT |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | S57 | Sugiyama | PDAP1 HASPP28 | EEEQKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGV |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13501 | S24 | Sugiyama | SQSTM1 ORCA OSIL | LTVKAYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPC |
| Q13541 | S65 | SIGNOR|iPTMNet|EPSD | EIF4EBP1 | ttPGGtRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPs |
| Q13541 | T36 | iPTMNet|EPSD | EIF4EBP1 | PATRRVVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDR |
| Q13541 | T37 | SIGNOR | EIF4EBP1 | ATRRVVLGDGVQLPPGDysttPGGtLFsttPGGtRIIyDRK |
| Q13541 | T45 | SIGNOR|iPTMNet|EPSD | EIF4EBP1 | DGVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRNs |
| Q13541 | T46 | SIGNOR | EIF4EBP1 | GVQLPPGDysttPGGtLFsttPGGtRIIyDRKFLMECRNsP |
| Q13541 | T70 | SIGNOR | EIF4EBP1 | tRIIyDRKFLMECRNsPVtKtPPRDLPtIPGVtsPssDEPP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q14011 | S163 | Sugiyama | CIRBP A18HNRNP CIRP | SSRsQsGGYSDRssGGsyRDsyDsyATHNE___________ |
| Q14151 | S818 | Sugiyama | SAFB2 KIAA0138 | QHYGDDRHGHGGPPERHGRDsRDGWGGyGsDKRLsEGRGLP |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14204 | S4368 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | MLEDEDDLAyAETEKKTRtDstsDGRPAWMRTLHTTASNWL |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14498 | S336 | Sugiyama | RBM39 HCC1 RNPC2 | LAGRPMKVGHVTERtDAssAssFLDsDELERtGIDLGtTGR |
| Q14566 | S498 | Sugiyama | MCM6 | EQQTISITKAGVKATLNARTsILAAANPIsGHyDRSKSLKQ |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14676 | T447 | Sugiyama | MDC1 KIAA0170 NFBD1 | WNRDAEEDMPQRVVLLQRsQtttERDsDtDVEEEELPVENR |
| Q14697 | S187 | Sugiyama | GANAB G2AN KIAA0088 | LLsVNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRD |
| Q14847 | S146 | Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14978 | S87 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KLQANGPVAKKAKKKAsssDsEDssEEEEEVQGPPAKKAAV |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15365 | T127 | Sugiyama | PCBP1 | TQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15366 | T127 | Sugiyama | PCBP2 | sQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15424 | S794 | Sugiyama | SAFB HAP HET SAFB1 | EREGQHYPERHGGPERHGRDsRDGWGGyGsDKRMsEGRGLP |
| Q15527 | S183 | Sugiyama | SURF2 | sDDsMtDLYPPELFTRKDLGstEDGDGtDDFLtDKEDEKAK |
| Q15545 | S171 | Sugiyama | TAF7 TAF2F TAFII55 | TAKKKYIEsPDVEKEVKRLLstDAEAVSTRWEIIAEDETKE |
| Q15643 | S464 | Sugiyama | TRIP11 CEV14 | SLLKLNNEyEVIKSTATRDIsLDsELHDLRLNLEAKEQELN |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q15831 | S428 | iPTMNet|EPSD | STK11 LKB1 PJS | GRAPNPARKACSASSKIRRLsACKQQ_______________ |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16695 | S11 | SIGNOR|iPTMNet|EPSD | H3-4 H3FT HIST3H3 | __________MARtKQTARKsTGGKAPRKQLATKVARKsAP |
| Q16695 | S29 | GPS6|SIGNOR|iPTMNet|EPSD | H3-4 H3FT HIST3H3 | RKsTGGKAPRKQLATKVARKsAPATGGVKKPHRyRPGtVAL |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q16778 | S39 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | VTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKA |
| Q2NKX8 | S1028 | Sugiyama | ERCC6L PICH | DEPEEVVVKAKIRSKARRIVsDGEDEDDsFKDtssINPFNT |
| Q32MZ4 | S120 | Sugiyama | LRRFIP1 GCF2 TRIP | MPGLSAAtLAsLGGtssRRGsGDtsISIDTEASIREIKELN |
| Q32MZ4 | S124 | Sugiyama | LRRFIP1 GCF2 TRIP | SAAtLAsLGGtssRRGsGDtsISIDTEASIREIKELNELKD |
| Q32MZ4 | T123 | Sugiyama | LRRFIP1 GCF2 TRIP | LSAAtLAsLGGtssRRGsGDtsISIDTEASIREIKELNELK |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q4G0J3 | T257 | Sugiyama | LARP7 HDCMA18P | KEENMDtsNtsIsKMKRsRPtsEGsDIEstEPQKQCSKKKK |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5JTW2 | S644 | Sugiyama | CEP78 C9orf81 | EGLGTSSNNLGVPATEQRQEsFEGFIARMCsPSPDATSGTG |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SW79 | S881 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | sstPssLALtsAsRIRERsEsLDPDssMDTtLILKDTEAVM |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5TCZ1 | S1038 | Sugiyama | SH3PXD2A FISH KIAA0418 SH3MD1 TKS5 | FSTARSAAAEAKGRLAERAAsQGsDsPLLPAQRNsIPVsPV |
| Q5TCZ1 | S1041 | Sugiyama | SH3PXD2A FISH KIAA0418 SH3MD1 TKS5 | ARSAAAEAKGRLAERAAsQGsDsPLLPAQRNsIPVsPVRPK |
| Q5VT52 | S1068 | Sugiyama | RPRD2 KIAA0460 HSPC099 | SLTATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETL |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q5VYS8 | S132 | Sugiyama | TUT7 HS2 KIAA1711 ZCCHC6 | NWREFKPGPRIPVINRQRKDsFQENEDGYRWQDTRGCRTVR |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DN03 | S39 | Sugiyama | H2BC20P HIST2H2BC | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S39 | Sugiyama | H2BC19P HIST2H2BD | VTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKA |
| Q6FI13 | S2 | GPS6|EPSD | H2AC18 H2AFO HIST2H2AA HIST2H2AA3; H2AC19 HIST2H2AA4 | ___________________MsGRGKQGGKARAKAKSRssRA |
| Q6GYQ0 | T798 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | tGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDMS |
| Q6P158 | S605 | Sugiyama | DHX57 | SLNGPPEKVANIICTQPRRIsAISVAERVAKERAERVGLTV |
| Q6P1L5 | S208 | Sugiyama | FAM117B ALS2CR13 | PEKRSPsAPVCKAGDKTRQPsssPsSIIRRtssLDtLAAPY |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S824 | Sugiyama | LARP1 KIAA0731 LARP | VKEGRTLDAKMPRKRKtRHssNPPLEsHVGWVMDSREHRPR |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q6ZUT9 | S691 | Sugiyama | DENND5B | NRWVSRSATAQRRKERLRQHsEHVGLDNDLREKYMQEARSL |
| Q70E73 | S996 | Sugiyama | RAPH1 ALS2CR18 ALS2CR9 KIAA1681 LPD PREL2 RMO1 | QRNssIKsSSGAEHPEPKRPsVDSLVSKFtPPAEsGsPsKE |
| Q71DI3 | S11 | GPS6 | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | __________MARtKQTARKsTGGKAPRKQLATKAARKsAP |
| Q71DI3 | S29 | GPS6 | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | RKsTGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q76FK4 | S296 | Sugiyama | NOL8 C9orf34 NOP132 | QKLKNLPFKTSGLETAKKRNsIsDDDtDsEDELRMMIAKEE |
| Q7L7L0 | S2 | GPS6|SIGNOR|iPTMNet|EPSD | H2AC25 H2AW HIST3H2A | ___________________MsGRGKQGGKARAKAKSRSsRA |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z401 | S1225 | Sugiyama | DENND4A IRLB MYCPBP | AEEIVMYMNNMssPLTSRtPsIDLQRACDDKLNKKsPPLVK |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z4V5 | S395 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | REDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKK |
| Q7Z4V5 | S396 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKP |
| Q7Z5L9 | S15 | Sugiyama | IRF2BP2 | ______MAAAVAVAAASRRQsCyLCDLPRMPWAMIWDFTEP |
| Q7Z5L9 | S455 | Sugiyama | IRF2BP2 | AGGSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVG |
| Q7Z5L9 | Y17 | Sugiyama | IRF2BP2 | ____MAAAVAVAAASRRQsCyLCDLPRMPWAMIWDFTEPVC |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86V48 | S957 | Sugiyama | LUZP1 | PTRIGKNVESTNSNAytQRsstDFsELEQPRSCLFEQGTRR |
| Q86V81 | S142 | Sugiyama | ALYREF ALY BEF THOC4 | IQELFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKA |
| Q86V81 | S145 | Sugiyama | ALYREF ALY BEF THOC4 | LFAEFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQ |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IUE6 | S2 | GPS6|EPSD | H2AC21 HIST2H2AB | ___________________MsGRGKQGGKARAKAKSRssRA |
| Q8IWT6 | S217 | PSP | LRRC8A KIAA1437 LRRC8 SWELL1 UNQ221/PRO247 | KsstVsEDVEATVPMLQRtKsRIEQGIVDRSETGVLDKKEG |
| Q8IX12 | S1091 | Sugiyama | CCAR1 CARP1 DIS | NLENsNKsLsGELREVKKDLsQLQENLKISENMNLQFENQM |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8N0Z3 | S810 | Sugiyama | SPICE1 CCDC52 SPICE | APESSKCSTVsPVSGINTRRssGATGNSCsPLNATSGSGRF |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N257 | S39 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | VTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKA |
| Q8N6T3 | S345 | Sugiyama | ARFGAP1 ARF1GAP | DQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWE |
| Q8N6T3 | S361 | Sugiyama | ARFGAP1 ARF1GAP | RKsPssDsWtCADtstERRssDsWEVWGSASTNRNSNsDGG |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8NBJ7 | T165 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | LHVSWNDARAYCAWRGKRLPtEEEWEFAARGGLKGQVYPWG |
| Q8NBK3 | T372 | Sugiyama | SUMF1 PSEC0152 UNQ3037/PRO9852 | NTPDSsAsNLGFRCAADRLPtMD__________________ |
| Q8ND56 | T384 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | DKTKsFFDNIsCDDNRERRPtWAEERRLNAETFGIPLRPNR |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8WWI1 | S805 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | LQDRESQNQKSTVPSRRRMysFDDVLEEGKRPPtMtVSEAS |
| Q8WWI1 | Y804 | Sugiyama | LMO7 FBX20 FBXO20 KIAA0858 | MLQDRESQNQKSTVPSRRRMysFDDVLEEGKRPPtMtVSEA |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q92934 | S118 | SIGNOR | BAD BBC6 BCL2L8 | RsAPPNLWAAQRYGRELRRMsDEFVDsFKKGLPRPKsAGtA |
| Q92934 | S153 | iPTMNet|EPSD | BAD BBC6 BCL2L8 | KsAGtATQMRQSSSWTRVFQsWWDRNLGRGSSAPSQ_____ |
| Q93077 | S2 | GPS6|EPSD | H2AC6 H2AFL HIST1H2AC | ___________________MsGRGKQGGKARAKAKSRssRA |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q96AQ6 | S147 | Sugiyama | PBXIP1 HPIP | PQSLPSTPKAAWIREEGRCsssDDDTDVDMEGLRRRRGREA |
| Q96BY7 | S497 | Sugiyama | ATG2B C14orf103 | PSNLVHPTPLQKtsLPsRsVsVDESRPELIFRLAVGTFSIS |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96C19 | S76 | Sugiyama | EFHD2 SWS1 | SAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKD |
| Q96C86 | S24 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | AAPQLGKRKRELDVEEAHAAstEEKEAGVGNGTCAPVRLPF |
| Q96C86 | T25 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | APQLGKRKRELDVEEAHAAstEEKEAGVGNGTCAPVRLPFS |
| Q96CW6 | S32 | Sugiyama | SLC7A6OS | KRKRsAEPAEALVLACKRLRsDAVESAAQKTSEGLERAAEN |
| Q96CW6 | T177 | Sugiyama | SLC7A6OS | KTSDPDVILCNsVELIRERLtVSEDGPGVRRQEEQKHDDYV |
| Q96D71 | S273 | Sugiyama | REPS1 | QTTVRTVASATTAIEIRRQsssyDDPWKItDEQRQYYVNQF |
| Q96G46 | S276 | Sugiyama | DUS3L | RQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRLRPC |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96IZ0 | T230 | Sugiyama | PAWR PAR4 | GSsyLLQEPPRTVSGRyKsttsVsEEDVsSRYsRTDRSGFP |
| Q96JP5 | S85 | Sugiyama | ZFP91 ZNF757 FKSG11 | AAAVSRRRKAEYPRRRRssPsARPPDVPGQQPQAAKsPsPV |
| Q96KK5 | S2 | GPS6|EPSD | H2AC12 HIST1H2AH HIST1H2AI | ___________________MsGRGKQGGKARAKAKTRssRA |
| Q96MH2 | S194 | Sugiyama | HEXIM2 L3 | EAGDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELV |
| Q96MH2 | T196 | Sugiyama | HEXIM2 L3 | GDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELVRD |
| Q96PK6 | S520 | Sugiyama | RBM14 SIP | AAAAYGAQPSATLAAPYRtQssAsLAAsYAAQQHPQAAASY |
| Q96QV6 | S2 | GPS6|EPSD | H2AC1 H2AFR HIST1H2AA | ___________________MsGRGKQGGKARAKSKSRSsRA |
| Q96RU3 | S497 | Sugiyama | FNBP1 FBP17 KIAA0554 | AWLAEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREs |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99878 | S2 | GPS6|EPSD | H2AC14 H2AFE HIST1H2AJ | ___________________MsGRGKQGGKARAKAKTRssRA |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BRA2 | S41 | Sugiyama | TXNDC17 TXNL5 | QHNGKTIFAyFTGSKDAGGKsWCPDCVQAEPVVREGLKHIS |
| Q9BTC0 | S1456 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | EAKVTVDDLPNRMCADVRRNsVERPAEPVAGAAtPsLVEQQ |
| Q9BTE6 | S174 | Sugiyama | AARSD1 | IEQSVNEKIRDRLPVNVRELsLDDPEVEQVsGRGLPDDHAG |
| Q9BW19 | T159 | Sugiyama | KIFC1 HSET KNSL2 | LKGQLCDLNAELKRCRERtQtLDQENQQLQDQLRDAQQQVK |
| Q9BW27 | S652 | Sugiyama | NUP85 NUP75 PCNT1 | VEMLRLSLARNLARAIIREGsLEGS________________ |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BZL6 | S197 | Sugiyama | PRKD2 PKD2 HSPC187 | HKRCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPC |
| Q9BZL6 | S198 | Sugiyama | PRKD2 PKD2 HSPC187 | KRCAFsIPNNCsGARKRRLsstsLAsGHsVRLGtsEsLPCT |
| Q9C0C2 | S1620 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ADsDAHLFQDSTEPRAsRVPssDEEVVEEPQsRRTRMsLGT |
| Q9C0C2 | S221 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TyGtTTAPRDEDGstLFRGWsQEGPVKsPAECREEHsKtPE |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9C0C2 | S920 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | QDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLGTy |
| Q9C0C2 | Y918 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | AsQDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLG |
| Q9C0H5 | S604 | Sugiyama | ARHGAP39 KIAA1688 | GYESDGALPLPMPGPVVRAFsEDEALAQQENRHWRRGtFEK |
| Q9H2U1 | S268 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | YIERGKGSACRIVCTQPRRIsAISVAERVAAERAEsCGSGN |
| Q9H3H1 | S431 | Sugiyama | TRIT1 IPT MOD5 | AAHIKSKSHLNQLKKRRRLDsDAVNTIEsQsVsPDHNKEPK |
| Q9H4A3 | T60 | EPSD|PSP | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GAAAADAVtGRtEEyRRRRHtMDKDSRGAAAtTtTTEHRFF |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9HAU0 | S471 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | MARYPEGYRtLPRNSKTRPEsICSVtPsTHDKTLGPGAEEK |
| Q9HCD5 | S378 | Sugiyama | NCOA5 KIAA1637 | EETDKIINYLRERKERLMRsstDsLPGPISRQPLGATSGAS |
| Q9NP61 | S367 | Sugiyama | ARFGAP3 ARFGAP1 | DsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDT |
| Q9NRA8 | S353 | Sugiyama | EIF4ENIF1 | SASRFSRWFSNPsRsGsRsssLGstPHEELERLAGLEQAIL |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NTI5 | S1257 | Sugiyama | PDS5B APRIN AS3 KIAA0979 | LVQEQKPKGSQRSRKRGHtAsEsDEQQWPEEKRLKEDILEN |
| Q9NUU7 | T467 | Sugiyama | DDX19A DDX19L | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9NVU7 | T552 | Sugiyama | SDAD1 NUC130 | SMPMEERKAKAAAISTSRVLtQEDFQKIRMAQMRKELDAAP |
| Q9NVW2 | T196 | Sugiyama | RLIM RNF12 | VENPRSESTSARPSRsERNstEALTEVPPTRGQRRARSRsP |
| Q9NYF8 | S320 | Sugiyama | BCLAF1 BTF KIAA0164 | sPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKRF |
| Q9NZN8 | S242 | Sugiyama | CNOT2 CDC36 NOT2 HSPC131 MSTP046 | VTGLDLSDFPALADRNRREGsGNPtPLINPLAGRAPYVGMV |
| Q9P2N2 | S69 | Sugiyama | ARHGAP28 KIAA1314 | RINRMLsNESLHPPAFsRSNsEASVDSASMEDFWREIESIK |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S338 | Sugiyama | NDRG3 | SASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsDGtQES |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UHI6 | T748 | Sugiyama | DDX20 DP103 GEMIN3 | SQRAKQSRRNLPRRSsFRLQtEAQEDDWyDCHREIRLSFSD |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKJ3 | S890 | Sugiyama | GPATCH8 GPATC8 KIAA0553 | YSSSSDASSDQSCYSRQRSYsDDSYSDYSDRSRRHSKRSHD |
| Q9UKV3 | S561 | Sugiyama | ACIN1 ACINUS KIAA0670 | GITEECLKQPsLEQKEGRRAsHtLLPSHRLKQSADSSSSRS |
| Q9UKV3 | T563 | Sugiyama | ACIN1 ACINUS KIAA0670 | TEECLKQPsLEQKEGRRAsHtLLPSHRLKQSADSSSSRSSS |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9ULD2 | T1204 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | ENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRLs |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UMR2 | T468 | Sugiyama | DDX19B DBP5 DDX19 TDBP | SMNILNRIQEHFNKKIERLDtDDLDEIEKIAN_________ |
| Q9UNE7 | S149 | Sugiyama | STUB1 CHIP PP1131 | LNFGDDIPsALRIAKKKRWNsIEERRIHQESELHSYLSRLI |
| Q9UNF1 | S264 | Sugiyama | MAGED2 BCG1 | sLRsPKARRGKARRRAAKLQssQEPEAPPPRDVALLQGRAN |
| Q9UNF1 | S265 | Sugiyama | MAGED2 BCG1 | LRsPKARRGKARRRAAKLQssQEPEAPPPRDVALLQGRAND |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UNN5 | S582 | Sugiyama | FAF1 UBXD12 UBXN3A CGI-03 | PPEPKEENAEPVSKLRIRtPsGEFLERRFLASNKLQIVFDF |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1101 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEF |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S1542 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDss |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y314 | S36 | Sugiyama | NOSIP CGI-25 | YHEKKKDTAAsGYGtQNIRLsRDAVKDFDCCCLSLQPCHDP |
| Q9Y314 | T30 | Sugiyama | NOSIP CGI-25 | AGAVyTYHEKKKDTAAsGYGtQNIRLsRDAVKDFDCCCLSL |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y4C1 | S264 | PSP | KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA | VHDNLVTCGNSARIGAVKRKssENNGTLVSKQAKsCsEAsP |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y608 | S18 | Sugiyama | LRRFIP2 | ___MGTPASGRKRTPVKDRFsAEDEALsNIAREAEARLAAK |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| NRAGE signals death through JNK | R-HSA-193648 | 8.467467e-09 | 8.072 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.950441e-08 | 7.100 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.031795e-07 | 6.986 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.183712e-07 | 6.661 | 1 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.616484e-07 | 6.582 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.997731e-07 | 6.523 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.816364e-07 | 6.418 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.210719e-06 | 5.655 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.258874e-06 | 5.487 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.150664e-06 | 5.211 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.223797e-06 | 5.206 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.586795e-05 | 4.799 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.551001e-05 | 4.809 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.137852e-05 | 4.670 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.579334e-05 | 4.446 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.171547e-05 | 4.210 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.280003e-05 | 4.138 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.795780e-05 | 4.108 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 7.934281e-05 | 4.100 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.454203e-05 | 4.024 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.114068e-04 | 3.953 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.469549e-04 | 3.833 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.603506e-04 | 3.795 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.829124e-04 | 3.738 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.790763e-04 | 3.747 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.966056e-04 | 3.706 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.133613e-04 | 3.671 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.134891e-04 | 3.671 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.204907e-04 | 3.657 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.386003e-04 | 3.622 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.799657e-04 | 3.553 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.799657e-04 | 3.553 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.279716e-04 | 3.484 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.530435e-04 | 3.452 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.754047e-04 | 3.426 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.441792e-04 | 3.352 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.826890e-04 | 3.316 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.076780e-04 | 3.294 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.118659e-04 | 3.291 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.806849e-04 | 3.236 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.575872e-04 | 3.182 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 6.792320e-04 | 3.168 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.051990e-04 | 3.094 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.679948e-04 | 3.115 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.838864e-04 | 3.106 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.838864e-04 | 3.106 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 8.322008e-04 | 3.080 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.510479e-04 | 3.022 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 9.391985e-04 | 3.027 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.011752e-03 | 2.995 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.122145e-03 | 2.950 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.202977e-03 | 2.920 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.234503e-03 | 2.909 | 1 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.319685e-03 | 2.880 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.285841e-03 | 2.891 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.422624e-03 | 2.847 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.431727e-03 | 2.844 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.482835e-03 | 2.829 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.545290e-03 | 2.811 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.750015e-03 | 2.757 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.712793e-03 | 2.766 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.826009e-03 | 2.738 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.236185e-03 | 2.650 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.204485e-03 | 2.657 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.204485e-03 | 2.657 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.187339e-03 | 2.660 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.338248e-03 | 2.631 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.695754e-03 | 2.569 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.695754e-03 | 2.569 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.746283e-03 | 2.561 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.790593e-03 | 2.554 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.892169e-03 | 2.539 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.892597e-03 | 2.539 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.078823e-03 | 2.512 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.087630e-03 | 2.510 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.156658e-03 | 2.501 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.156658e-03 | 2.501 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.156658e-03 | 2.501 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.171070e-03 | 2.499 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.362702e-03 | 2.473 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.444995e-03 | 2.463 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.630310e-03 | 2.440 | 1 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.026594e-03 | 2.395 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.026594e-03 | 2.395 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.269355e-03 | 2.370 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.340106e-03 | 2.362 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.421620e-03 | 2.354 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.792541e-03 | 2.319 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.771096e-03 | 2.239 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.906301e-03 | 2.229 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 6.023823e-03 | 2.220 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 6.023823e-03 | 2.220 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.068888e-03 | 2.217 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.136007e-03 | 2.212 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.347559e-03 | 2.197 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.421195e-03 | 2.192 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.873872e-03 | 2.163 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.874489e-03 | 2.163 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.984244e-03 | 2.156 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.314695e-03 | 2.136 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.361713e-03 | 2.133 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.157196e-03 | 2.088 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.175239e-03 | 2.087 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 8.286950e-03 | 2.082 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.457095e-03 | 2.073 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.502807e-03 | 2.070 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.734830e-03 | 2.059 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 8.734830e-03 | 2.059 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.067562e-02 | 1.972 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.067562e-02 | 1.972 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.007586e-02 | 1.997 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.656595e-03 | 2.015 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.502518e-03 | 2.022 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.013476e-02 | 1.994 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.013476e-02 | 1.994 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.007586e-02 | 1.997 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.052406e-02 | 1.978 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.012794e-02 | 1.994 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.065257e-02 | 1.973 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.065257e-02 | 1.973 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.067562e-02 | 1.972 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.044968e-02 | 1.981 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.067562e-02 | 1.972 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.054653e-02 | 1.977 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.074495e-02 | 1.969 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.074495e-02 | 1.969 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.101988e-02 | 1.958 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.242425e-02 | 1.906 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.175209e-02 | 1.930 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.154026e-02 | 1.938 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.241713e-02 | 1.906 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.241713e-02 | 1.906 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.178425e-02 | 1.929 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.302031e-02 | 1.885 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.330107e-02 | 1.876 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.330107e-02 | 1.876 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.363471e-02 | 1.865 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.369325e-02 | 1.863 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.409292e-02 | 1.851 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.584870e-02 | 1.800 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.554123e-02 | 1.809 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.578793e-02 | 1.802 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.573882e-02 | 1.803 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.475401e-02 | 1.831 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.501937e-02 | 1.823 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.519390e-02 | 1.818 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.635204e-02 | 1.786 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.657914e-02 | 1.780 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.689898e-02 | 1.772 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.691024e-02 | 1.772 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.717956e-02 | 1.765 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.742235e-02 | 1.759 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.766981e-02 | 1.753 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.780236e-02 | 1.750 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.807932e-02 | 1.743 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.974293e-02 | 1.705 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.989694e-02 | 1.701 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.819095e-02 | 1.740 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.006598e-02 | 1.698 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.041151e-02 | 1.690 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.046646e-02 | 1.689 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.082180e-02 | 1.681 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.163052e-02 | 1.665 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.221322e-02 | 1.653 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.261558e-02 | 1.646 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.270538e-02 | 1.644 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.400782e-02 | 1.620 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.492421e-02 | 1.603 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.537586e-02 | 1.596 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.584996e-02 | 1.588 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.623136e-02 | 1.581 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.655032e-02 | 1.576 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.854549e-02 | 1.544 | 1 | 1 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.994896e-02 | 1.524 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.051062e-02 | 1.516 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.064137e-02 | 1.514 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.129851e-02 | 1.504 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.168134e-02 | 1.499 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.226620e-02 | 1.491 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.531564e-02 | 1.452 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.451999e-02 | 1.462 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.451999e-02 | 1.462 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.370160e-02 | 1.472 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.488882e-02 | 1.457 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.542933e-02 | 1.451 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.359628e-02 | 1.474 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.324074e-02 | 1.478 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.476559e-02 | 1.459 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 3.531564e-02 | 1.452 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.280830e-02 | 1.484 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.504251e-02 | 1.455 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.488882e-02 | 1.457 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.488882e-02 | 1.457 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.667565e-02 | 1.436 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.710389e-02 | 1.431 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.714377e-02 | 1.430 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 3.922169e-02 | 1.406 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.967631e-02 | 1.401 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 4.087387e-02 | 1.389 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 4.087387e-02 | 1.389 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.316831e-02 | 1.365 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.341580e-02 | 1.362 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.341580e-02 | 1.362 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.341580e-02 | 1.362 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.341580e-02 | 1.362 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.341580e-02 | 1.362 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.353193e-02 | 1.361 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.374822e-02 | 1.359 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.499222e-02 | 1.347 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 4.987084e-02 | 1.302 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.151045e-02 | 1.288 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.151045e-02 | 1.288 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.151045e-02 | 1.288 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.151045e-02 | 1.288 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.555483e-02 | 1.341 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.555483e-02 | 1.341 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.812165e-02 | 1.318 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.716079e-02 | 1.326 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.959296e-02 | 1.305 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.532127e-02 | 1.344 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.109781e-02 | 1.292 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.151045e-02 | 1.288 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.681369e-02 | 1.330 | 1 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.163566e-02 | 1.287 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.177302e-02 | 1.286 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.290369e-02 | 1.277 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.332415e-02 | 1.273 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.449410e-02 | 1.264 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.538823e-02 | 1.257 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.538823e-02 | 1.257 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.568490e-02 | 1.254 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 5.589377e-02 | 1.253 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.589377e-02 | 1.253 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 5.589377e-02 | 1.253 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 5.589377e-02 | 1.253 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.599701e-02 | 1.252 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.655779e-02 | 1.248 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.665294e-02 | 1.247 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.829470e-02 | 1.234 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.829470e-02 | 1.234 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.829470e-02 | 1.234 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.838899e-02 | 1.234 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.497742e-02 | 1.187 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.581223e-02 | 1.182 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.047455e-02 | 1.218 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.047455e-02 | 1.218 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.047455e-02 | 1.218 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.991561e-02 | 1.222 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.991561e-02 | 1.222 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.047455e-02 | 1.218 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.974015e-02 | 1.224 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.327635e-02 | 1.199 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.231171e-02 | 1.205 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.866895e-02 | 1.163 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.895194e-02 | 1.161 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.034059e-02 | 1.153 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.034059e-02 | 1.153 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.034059e-02 | 1.153 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 7.034059e-02 | 1.153 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.038256e-02 | 1.153 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.041374e-02 | 1.152 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.041374e-02 | 1.152 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 7.066690e-02 | 1.151 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 7.066690e-02 | 1.151 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 7.066690e-02 | 1.151 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.066690e-02 | 1.151 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.066690e-02 | 1.151 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.368767e-02 | 1.133 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.448065e-02 | 1.128 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.467602e-02 | 1.127 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 8.217017e-02 | 1.085 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 8.217017e-02 | 1.085 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 8.217017e-02 | 1.085 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.666559e-02 | 1.062 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 8.666559e-02 | 1.062 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 8.666559e-02 | 1.062 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 8.666559e-02 | 1.062 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.764123e-02 | 1.110 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.764123e-02 | 1.110 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.153107e-02 | 1.038 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.153107e-02 | 1.038 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.153107e-02 | 1.038 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 9.153107e-02 | 1.038 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.203850e-02 | 1.086 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.450193e-02 | 1.073 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.450193e-02 | 1.073 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.538402e-02 | 1.069 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.658158e-02 | 1.116 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.708777e-02 | 1.060 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.574520e-02 | 1.067 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.876606e-02 | 1.104 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.876606e-02 | 1.104 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.783888e-02 | 1.109 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.788399e-02 | 1.109 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.450193e-02 | 1.073 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 8.666559e-02 | 1.062 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 9.153107e-02 | 1.038 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.465108e-02 | 1.072 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.159016e-02 | 1.038 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 9.252940e-02 | 1.034 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 9.252940e-02 | 1.034 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.441765e-02 | 1.025 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.564584e-02 | 1.019 | 1 | 0 |
| Integrin signaling | R-HSA-354192 | 9.599589e-02 | 1.018 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.599589e-02 | 1.018 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.694434e-02 | 1.013 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.852955e-02 | 1.006 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.912577e-02 | 1.004 | 1 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.115746e-01 | 0.952 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.115746e-01 | 0.952 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.115746e-01 | 0.952 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.115746e-01 | 0.952 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.115746e-01 | 0.952 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.115746e-01 | 0.952 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.115746e-01 | 0.952 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.115746e-01 | 0.952 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.190912e-01 | 0.924 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.190912e-01 | 0.924 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.190912e-01 | 0.924 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.167949e-01 | 0.933 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.167949e-01 | 0.933 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.167949e-01 | 0.933 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.167949e-01 | 0.933 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.045584e-01 | 0.981 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.239781e-01 | 0.907 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.239781e-01 | 0.907 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.228121e-01 | 0.911 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.045674e-01 | 0.981 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.006931e-01 | 0.997 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.006931e-01 | 0.997 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.006931e-01 | 0.997 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.127830e-01 | 0.948 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.127830e-01 | 0.948 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.004705e-01 | 0.998 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.105064e-01 | 0.957 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.105064e-01 | 0.957 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.105064e-01 | 0.957 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.064763e-01 | 0.973 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.221321e-01 | 0.913 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.055189e-01 | 0.977 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.143213e-01 | 0.942 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.143213e-01 | 0.942 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.143213e-01 | 0.942 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.179460e-01 | 0.928 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.062178e-01 | 0.974 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.179460e-01 | 0.928 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.105064e-01 | 0.957 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.141457e-01 | 0.943 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.931096e-02 | 1.003 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.147015e-01 | 0.940 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.235642e-01 | 0.908 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.045674e-01 | 0.981 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.153082e-01 | 0.938 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.167949e-01 | 0.933 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.045584e-01 | 0.981 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.045584e-01 | 0.981 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.221321e-01 | 0.913 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.006931e-01 | 0.997 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.208944e-01 | 0.918 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.208944e-01 | 0.918 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.208944e-01 | 0.918 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.245640e-01 | 0.905 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.255995e-01 | 0.901 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.255995e-01 | 0.901 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.298238e-01 | 0.887 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.301231e-01 | 0.886 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.321785e-01 | 0.879 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.328011e-01 | 0.877 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.329341e-01 | 0.876 | 1 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.331869e-01 | 0.876 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.348030e-01 | 0.870 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.391177e-01 | 0.857 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.391177e-01 | 0.857 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.400837e-01 | 0.854 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.400837e-01 | 0.854 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.400837e-01 | 0.854 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.400837e-01 | 0.854 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.400837e-01 | 0.854 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.401869e-01 | 0.853 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.408735e-01 | 0.851 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.418121e-01 | 0.848 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.440670e-01 | 0.841 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.440670e-01 | 0.841 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.447931e-01 | 0.839 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.447931e-01 | 0.839 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.487513e-01 | 0.828 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.107061e-01 | 0.676 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.107061e-01 | 0.676 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.107061e-01 | 0.676 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.107061e-01 | 0.676 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.107061e-01 | 0.676 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.107061e-01 | 0.676 | 0 | 0 |
| Tandem pore domain halothane-inhibited K+ channel (THIK) | R-HSA-1299287 | 2.107061e-01 | 0.676 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.107061e-01 | 0.676 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.592017e-01 | 0.798 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.592017e-01 | 0.798 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.592017e-01 | 0.798 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.987816e-01 | 0.525 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.987816e-01 | 0.525 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.987816e-01 | 0.525 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 2.987816e-01 | 0.525 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.987816e-01 | 0.525 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.987816e-01 | 0.525 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 2.987816e-01 | 0.525 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 2.987816e-01 | 0.525 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 2.987816e-01 | 0.525 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.987816e-01 | 0.525 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.987816e-01 | 0.525 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.987816e-01 | 0.525 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.987816e-01 | 0.525 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.013311e-01 | 0.696 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.013311e-01 | 0.696 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.013311e-01 | 0.696 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.712085e-01 | 0.766 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.445303e-01 | 0.612 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.445303e-01 | 0.612 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.445303e-01 | 0.612 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.445303e-01 | 0.612 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.770335e-01 | 0.424 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.770335e-01 | 0.424 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.770335e-01 | 0.424 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.770335e-01 | 0.424 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.770335e-01 | 0.424 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.770335e-01 | 0.424 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.770335e-01 | 0.424 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.770335e-01 | 0.424 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.770335e-01 | 0.424 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.770335e-01 | 0.424 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.770335e-01 | 0.424 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.770335e-01 | 0.424 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.770335e-01 | 0.424 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.770335e-01 | 0.424 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.006809e-01 | 0.697 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.006809e-01 | 0.697 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.880366e-01 | 0.541 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.880366e-01 | 0.541 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.312260e-01 | 0.636 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.312260e-01 | 0.636 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.900216e-01 | 0.721 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.583461e-01 | 0.800 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.775164e-01 | 0.751 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.775164e-01 | 0.751 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.141236e-01 | 0.669 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.625362e-01 | 0.581 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 2.625362e-01 | 0.581 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.312439e-01 | 0.480 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.312439e-01 | 0.480 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.312439e-01 | 0.480 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.312439e-01 | 0.480 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.312439e-01 | 0.480 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.312439e-01 | 0.480 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.312439e-01 | 0.480 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.312439e-01 | 0.480 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.465570e-01 | 0.350 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.465570e-01 | 0.350 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.465570e-01 | 0.350 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.465570e-01 | 0.350 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.465570e-01 | 0.350 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.465570e-01 | 0.350 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.465570e-01 | 0.350 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.465570e-01 | 0.350 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.465570e-01 | 0.350 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.465570e-01 | 0.350 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.650896e-01 | 0.782 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.975059e-01 | 0.704 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.390056e-01 | 0.622 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.390056e-01 | 0.622 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.533083e-01 | 0.814 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.533083e-01 | 0.814 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.943259e-01 | 0.531 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.943259e-01 | 0.531 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.943259e-01 | 0.531 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.182217e-01 | 0.661 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.998693e-01 | 0.699 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.645095e-01 | 0.578 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.736775e-01 | 0.428 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.736775e-01 | 0.428 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.736775e-01 | 0.428 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.835683e-01 | 0.736 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.835683e-01 | 0.736 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.395679e-01 | 0.621 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.395679e-01 | 0.621 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.181914e-01 | 0.661 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.181914e-01 | 0.661 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.263339e-01 | 0.486 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.263339e-01 | 0.486 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.614475e-01 | 0.583 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.370505e-01 | 0.625 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.167735e-01 | 0.499 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.167735e-01 | 0.499 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.149723e-01 | 0.382 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.083253e-01 | 0.294 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.083253e-01 | 0.294 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.083253e-01 | 0.294 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.083253e-01 | 0.294 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.083253e-01 | 0.294 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 5.083253e-01 | 0.294 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.083253e-01 | 0.294 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.917396e-01 | 0.717 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.064199e-01 | 0.514 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.064199e-01 | 0.514 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 3.064199e-01 | 0.514 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.064199e-01 | 0.514 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.432451e-01 | 0.464 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.432451e-01 | 0.464 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.432451e-01 | 0.464 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.432451e-01 | 0.464 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.432451e-01 | 0.464 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.900908e-01 | 0.409 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.900908e-01 | 0.409 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.900908e-01 | 0.409 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.900908e-01 | 0.409 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.293231e-01 | 0.482 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.697643e-01 | 0.432 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.697643e-01 | 0.432 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.548542e-01 | 0.342 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.548542e-01 | 0.342 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.370779e-01 | 0.472 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.108273e-01 | 0.507 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.962085e-01 | 0.402 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.926464e-01 | 0.534 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.640200e-01 | 0.578 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.785295e-01 | 0.422 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.931244e-01 | 0.307 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.931244e-01 | 0.307 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.632029e-01 | 0.249 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.632029e-01 | 0.249 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.632029e-01 | 0.249 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.632029e-01 | 0.249 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.632029e-01 | 0.249 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.632029e-01 | 0.249 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.632029e-01 | 0.249 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.632029e-01 | 0.249 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.632029e-01 | 0.249 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.632029e-01 | 0.249 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.632029e-01 | 0.249 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.993110e-01 | 0.399 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.216503e-01 | 0.375 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 4.823315e-01 | 0.317 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.445109e-01 | 0.352 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.159206e-01 | 0.381 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.740186e-01 | 0.324 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.296458e-01 | 0.276 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.296458e-01 | 0.276 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.296458e-01 | 0.276 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.296458e-01 | 0.276 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.302086e-01 | 0.366 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.116121e-01 | 0.291 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.116121e-01 | 0.291 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.116121e-01 | 0.291 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.116121e-01 | 0.291 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.559106e-01 | 0.341 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.991418e-01 | 0.302 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.815004e-01 | 0.317 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.746442e-01 | 0.324 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.859398e-01 | 0.313 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 5.399907e-01 | 0.268 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.399907e-01 | 0.268 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.399907e-01 | 0.268 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.643322e-01 | 0.248 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.330609e-01 | 0.273 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.477249e-01 | 0.261 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.477249e-01 | 0.261 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.296839e-01 | 0.276 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 5.673954e-01 | 0.246 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.328310e-01 | 0.273 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.710710e-01 | 0.243 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.710710e-01 | 0.243 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.710710e-01 | 0.243 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.971383e-01 | 0.224 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.971383e-01 | 0.224 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.971383e-01 | 0.224 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.650960e-01 | 0.248 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.748775e-01 | 0.240 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.823367e-01 | 0.235 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.937261e-01 | 0.226 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.937261e-01 | 0.226 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.937261e-01 | 0.226 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.950291e-01 | 0.225 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.155614e-01 | 0.501 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.647113e-01 | 0.783 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.504548e-01 | 0.601 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.993110e-01 | 0.399 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.755109e-01 | 0.425 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.673954e-01 | 0.246 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.863432e-01 | 0.543 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.303410e-01 | 0.638 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.370427e-01 | 0.359 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.370427e-01 | 0.359 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.432451e-01 | 0.464 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.680293e-01 | 0.572 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.141236e-01 | 0.669 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.904815e-01 | 0.537 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.815310e-01 | 0.741 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.643322e-01 | 0.248 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.597661e-01 | 0.797 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.733596e-01 | 0.761 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.815310e-01 | 0.741 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.821482e-01 | 0.740 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.116121e-01 | 0.291 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.969704e-01 | 0.224 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.535351e-01 | 0.257 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.900216e-01 | 0.721 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.263339e-01 | 0.486 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.114690e-01 | 0.291 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.857397e-01 | 0.314 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.712085e-01 | 0.766 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.904815e-01 | 0.537 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.282993e-01 | 0.641 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.894789e-01 | 0.310 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.355125e-01 | 0.474 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.355125e-01 | 0.474 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 3.442585e-01 | 0.463 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.712085e-01 | 0.766 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.312439e-01 | 0.480 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.681376e-01 | 0.774 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.645095e-01 | 0.578 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.835683e-01 | 0.736 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.128059e-01 | 0.672 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.700747e-01 | 0.769 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.548542e-01 | 0.342 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.548542e-01 | 0.342 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.611966e-01 | 0.336 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.859398e-01 | 0.313 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.785295e-01 | 0.422 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.116121e-01 | 0.291 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.577650e-01 | 0.446 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.650076e-01 | 0.782 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.108273e-01 | 0.507 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.599236e-01 | 0.252 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.592017e-01 | 0.798 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.592017e-01 | 0.798 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.445303e-01 | 0.612 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.625362e-01 | 0.581 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.736775e-01 | 0.428 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.736775e-01 | 0.428 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.736775e-01 | 0.428 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.001849e-01 | 0.699 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.042731e-01 | 0.690 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.755109e-01 | 0.425 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.632029e-01 | 0.249 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.643322e-01 | 0.248 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 5.477249e-01 | 0.261 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.971383e-01 | 0.224 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.736498e-01 | 0.325 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.311104e-01 | 0.365 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.293231e-01 | 0.482 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.969704e-01 | 0.224 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.006809e-01 | 0.697 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.880366e-01 | 0.541 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.064199e-01 | 0.514 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.643322e-01 | 0.248 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.503118e-01 | 0.456 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.800332e-01 | 0.420 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.467072e-01 | 0.350 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.314741e-01 | 0.635 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.214482e-01 | 0.375 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.743000e-01 | 0.241 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.792148e-01 | 0.747 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.477230e-01 | 0.459 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.785295e-01 | 0.422 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.352215e-01 | 0.271 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.491811e-01 | 0.457 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.461545e-01 | 0.461 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.445303e-01 | 0.612 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.668587e-01 | 0.778 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.645095e-01 | 0.578 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.736775e-01 | 0.428 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.736775e-01 | 0.428 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.563810e-01 | 0.591 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.453666e-01 | 0.610 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.165308e-01 | 0.500 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.548542e-01 | 0.342 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.931244e-01 | 0.307 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.632029e-01 | 0.249 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.900421e-01 | 0.538 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.991418e-01 | 0.302 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.399907e-01 | 0.268 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.754989e-01 | 0.323 | 1 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.277150e-01 | 0.278 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.295740e-01 | 0.276 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.971383e-01 | 0.224 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.937261e-01 | 0.226 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.882364e-01 | 0.230 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.754989e-01 | 0.323 | 1 | 0 |
| Mitophagy | R-HSA-5205647 | 2.160687e-01 | 0.665 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.382230e-01 | 0.623 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.748775e-01 | 0.240 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.835683e-01 | 0.736 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.114690e-01 | 0.291 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.558991e-01 | 0.807 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.496841e-01 | 0.347 | 1 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.977354e-01 | 0.704 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.931244e-01 | 0.307 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.681376e-01 | 0.774 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.820813e-01 | 0.740 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.296458e-01 | 0.276 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.477249e-01 | 0.261 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.511664e-01 | 0.600 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.788920e-01 | 0.421 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.717128e-01 | 0.566 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.426067e-01 | 0.354 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.958650e-01 | 0.529 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.690152e-01 | 0.245 | 1 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.592017e-01 | 0.798 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.712085e-01 | 0.766 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 2.880366e-01 | 0.541 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.736775e-01 | 0.428 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.548542e-01 | 0.342 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.671410e-01 | 0.331 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.629473e-01 | 0.440 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.237311e-01 | 0.281 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.115640e-01 | 0.291 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.049946e-01 | 0.297 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.689825e-01 | 0.245 | 1 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.256212e-01 | 0.279 | 1 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.673954e-01 | 0.246 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.514719e-01 | 0.600 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.256212e-01 | 0.279 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.256212e-01 | 0.279 | 1 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.900216e-01 | 0.721 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.625362e-01 | 0.581 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.421235e-01 | 0.466 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.467072e-01 | 0.350 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.686782e-01 | 0.773 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.351316e-01 | 0.361 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.312439e-01 | 0.480 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.165308e-01 | 0.500 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.056052e-01 | 0.515 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.471620e-01 | 0.350 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.533083e-01 | 0.814 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.894789e-01 | 0.310 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.653291e-01 | 0.437 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.875849e-01 | 0.412 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.740186e-01 | 0.324 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.937261e-01 | 0.226 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 5.493359e-01 | 0.260 | 1 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.399907e-01 | 0.268 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.566519e-01 | 0.254 | 1 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.683142e-01 | 0.329 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.159206e-01 | 0.381 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.251281e-01 | 0.280 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.671410e-01 | 0.331 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.806220e-01 | 0.420 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.592017e-01 | 0.798 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.712085e-01 | 0.766 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.770335e-01 | 0.424 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.006809e-01 | 0.697 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.141236e-01 | 0.669 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.465570e-01 | 0.350 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.390056e-01 | 0.622 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.943259e-01 | 0.531 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.736775e-01 | 0.428 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.263339e-01 | 0.486 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.904815e-01 | 0.537 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.682359e-01 | 0.571 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.527700e-01 | 0.597 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.962085e-01 | 0.402 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.577650e-01 | 0.446 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.522397e-01 | 0.345 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.931244e-01 | 0.307 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.632029e-01 | 0.249 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.632029e-01 | 0.249 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.201553e-01 | 0.657 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.647350e-01 | 0.438 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.370427e-01 | 0.359 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.508330e-01 | 0.346 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.477249e-01 | 0.261 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.971383e-01 | 0.224 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.650960e-01 | 0.248 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.698598e-01 | 0.244 | 1 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.698598e-01 | 0.244 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.937261e-01 | 0.226 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.560270e-01 | 0.807 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.209708e-01 | 0.376 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.655646e-01 | 0.781 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.017860e-01 | 0.695 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.577204e-01 | 0.339 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.233367e-01 | 0.490 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.237311e-01 | 0.281 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.583251e-01 | 0.446 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.165308e-01 | 0.500 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.535351e-01 | 0.257 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.843379e-01 | 0.734 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.748775e-01 | 0.240 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.672250e-01 | 0.330 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 5.189600e-01 | 0.285 | 1 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.786521e-01 | 0.238 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.034143e-01 | 0.298 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.311104e-01 | 0.365 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.835683e-01 | 0.736 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.894789e-01 | 0.310 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.233367e-01 | 0.490 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.910893e-01 | 0.719 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.559106e-01 | 0.341 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 3.736775e-01 | 0.428 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.548542e-01 | 0.342 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.522397e-01 | 0.345 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.990619e-01 | 0.399 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.467072e-01 | 0.350 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.710710e-01 | 0.243 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.937711e-01 | 0.226 | 1 | 1 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.937261e-01 | 0.226 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.950291e-01 | 0.225 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.664388e-01 | 0.331 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.693749e-01 | 0.570 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.100251e-01 | 0.292 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.666872e-01 | 0.778 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 5.357994e-01 | 0.271 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.712085e-01 | 0.766 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.445303e-01 | 0.612 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.995598e-01 | 0.700 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.083253e-01 | 0.294 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.432451e-01 | 0.464 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.224653e-01 | 0.374 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.406977e-01 | 0.356 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.209708e-01 | 0.376 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.932068e-01 | 0.307 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.643322e-01 | 0.248 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.643322e-01 | 0.248 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.643322e-01 | 0.248 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.998693e-01 | 0.699 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.402422e-01 | 0.356 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.548542e-01 | 0.342 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.149723e-01 | 0.382 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.971383e-01 | 0.224 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.937261e-01 | 0.226 | 1 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.916373e-01 | 0.228 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.787046e-01 | 0.555 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.006809e-01 | 0.697 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.823315e-01 | 0.317 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.210725e-01 | 0.493 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.987816e-01 | 0.525 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.770335e-01 | 0.424 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.312260e-01 | 0.636 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.390056e-01 | 0.622 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.736775e-01 | 0.428 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.614475e-01 | 0.583 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.083253e-01 | 0.294 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 4.548542e-01 | 0.342 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 2.937738e-01 | 0.532 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.632029e-01 | 0.249 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.823315e-01 | 0.317 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.937711e-01 | 0.226 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.969704e-01 | 0.224 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 3.064199e-01 | 0.514 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.101784e-01 | 0.677 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.673954e-01 | 0.246 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 3.962085e-01 | 0.402 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.823315e-01 | 0.317 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.697643e-01 | 0.432 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.116121e-01 | 0.291 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.880366e-01 | 0.541 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 1.583461e-01 | 0.800 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.160687e-01 | 0.665 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.785295e-01 | 0.422 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.302086e-01 | 0.366 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.425303e-01 | 0.615 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.399907e-01 | 0.268 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.900908e-01 | 0.409 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.823315e-01 | 0.317 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 5.673954e-01 | 0.246 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.894789e-01 | 0.310 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.712085e-01 | 0.766 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 2.445303e-01 | 0.612 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.083253e-01 | 0.294 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.900908e-01 | 0.409 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.233367e-01 | 0.490 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.233367e-01 | 0.490 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.421235e-01 | 0.466 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.632029e-01 | 0.249 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.800332e-01 | 0.420 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 4.504169e-01 | 0.346 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.643322e-01 | 0.248 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.643322e-01 | 0.248 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.971383e-01 | 0.224 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.764837e-01 | 0.753 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.904815e-01 | 0.537 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.064199e-01 | 0.514 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.369578e-01 | 0.270 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.534274e-01 | 0.814 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.583251e-01 | 0.446 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.937711e-01 | 0.226 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 5.191396e-01 | 0.285 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.149723e-01 | 0.382 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.149723e-01 | 0.382 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.863432e-01 | 0.543 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.632029e-01 | 0.249 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.559106e-01 | 0.341 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.643322e-01 | 0.248 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.047268e-01 | 0.516 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.370779e-01 | 0.472 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.673954e-01 | 0.246 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.237311e-01 | 0.281 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.407608e-01 | 0.618 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.962085e-01 | 0.402 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.931244e-01 | 0.307 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.849415e-01 | 0.233 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.643322e-01 | 0.248 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.126797e-01 | 0.505 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.583251e-01 | 0.446 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.116121e-01 | 0.291 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.548542e-01 | 0.342 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.992369e-01 | 0.222 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.016721e-01 | 0.221 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.021696e-01 | 0.220 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.041729e-01 | 0.219 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 6.051371e-01 | 0.218 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 6.051371e-01 | 0.218 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.118557e-01 | 0.213 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.119584e-01 | 0.213 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.119584e-01 | 0.213 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.119584e-01 | 0.213 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.119584e-01 | 0.213 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.119584e-01 | 0.213 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.119584e-01 | 0.213 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.119584e-01 | 0.213 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.119584e-01 | 0.213 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.119584e-01 | 0.213 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.119584e-01 | 0.213 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.119584e-01 | 0.213 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.119584e-01 | 0.213 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.119584e-01 | 0.213 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.119584e-01 | 0.213 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.119584e-01 | 0.213 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.119584e-01 | 0.213 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.119584e-01 | 0.213 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.119584e-01 | 0.213 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.119584e-01 | 0.213 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.119584e-01 | 0.213 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.148549e-01 | 0.211 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.156549e-01 | 0.211 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.156549e-01 | 0.211 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.156549e-01 | 0.211 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.156549e-01 | 0.211 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.156549e-01 | 0.211 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.156549e-01 | 0.211 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.156549e-01 | 0.211 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.157769e-01 | 0.211 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.158699e-01 | 0.211 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.168805e-01 | 0.210 | 1 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.190784e-01 | 0.208 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.190784e-01 | 0.208 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.190784e-01 | 0.208 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.205032e-01 | 0.207 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.280516e-01 | 0.202 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.280516e-01 | 0.202 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.280516e-01 | 0.202 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.280516e-01 | 0.202 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.280516e-01 | 0.202 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.280516e-01 | 0.202 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.319396e-01 | 0.199 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.322851e-01 | 0.199 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.336750e-01 | 0.198 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.336750e-01 | 0.198 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.356868e-01 | 0.197 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 6.382590e-01 | 0.195 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.399073e-01 | 0.194 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.432912e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.432912e-01 | 0.192 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.432912e-01 | 0.192 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.432912e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.432912e-01 | 0.192 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.432912e-01 | 0.192 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.432912e-01 | 0.192 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.477098e-01 | 0.189 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.492441e-01 | 0.188 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.499072e-01 | 0.187 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.521259e-01 | 0.186 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.552742e-01 | 0.184 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.552742e-01 | 0.184 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 6.552742e-01 | 0.184 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 6.552742e-01 | 0.184 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 6.552742e-01 | 0.184 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.552742e-01 | 0.184 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.552742e-01 | 0.184 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.552742e-01 | 0.184 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.552742e-01 | 0.184 | 1 | 1 |
| NADPH regeneration | R-HSA-389542 | 6.552742e-01 | 0.184 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.552742e-01 | 0.184 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.552742e-01 | 0.184 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.570858e-01 | 0.182 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.570858e-01 | 0.182 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.570858e-01 | 0.182 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.570858e-01 | 0.182 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.570858e-01 | 0.182 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.570858e-01 | 0.182 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.570858e-01 | 0.182 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.570858e-01 | 0.182 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.570858e-01 | 0.182 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.570858e-01 | 0.182 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.570858e-01 | 0.182 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.572319e-01 | 0.182 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.572319e-01 | 0.182 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.604047e-01 | 0.180 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.613531e-01 | 0.180 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.613531e-01 | 0.180 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.644192e-01 | 0.178 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.657175e-01 | 0.177 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.663954e-01 | 0.176 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.663954e-01 | 0.176 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.663954e-01 | 0.176 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 6.699739e-01 | 0.174 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.724444e-01 | 0.172 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.755856e-01 | 0.170 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.768459e-01 | 0.170 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.768459e-01 | 0.170 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.768459e-01 | 0.170 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.816941e-01 | 0.166 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.842754e-01 | 0.165 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.842754e-01 | 0.165 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.842754e-01 | 0.165 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.842754e-01 | 0.165 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 6.842754e-01 | 0.165 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.870474e-01 | 0.163 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.872081e-01 | 0.163 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.872081e-01 | 0.163 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.876004e-01 | 0.163 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.883873e-01 | 0.162 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.883873e-01 | 0.162 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.883873e-01 | 0.162 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.883873e-01 | 0.162 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.937571e-01 | 0.159 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.937571e-01 | 0.159 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.937571e-01 | 0.159 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.937571e-01 | 0.159 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.937571e-01 | 0.159 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.937571e-01 | 0.159 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.937571e-01 | 0.159 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 6.937571e-01 | 0.159 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.937571e-01 | 0.159 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 6.937571e-01 | 0.159 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.937571e-01 | 0.159 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.937571e-01 | 0.159 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.937571e-01 | 0.159 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.937571e-01 | 0.159 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 6.937571e-01 | 0.159 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.937571e-01 | 0.159 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.937571e-01 | 0.159 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.937571e-01 | 0.159 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.937571e-01 | 0.159 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.956644e-01 | 0.158 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.956644e-01 | 0.158 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.971655e-01 | 0.157 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.971655e-01 | 0.157 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.997590e-01 | 0.155 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.997590e-01 | 0.155 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.004624e-01 | 0.155 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.026637e-01 | 0.153 | 1 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.038212e-01 | 0.153 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.042749e-01 | 0.152 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.042749e-01 | 0.152 | 1 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.050017e-01 | 0.152 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.075222e-01 | 0.150 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.092723e-01 | 0.149 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.092723e-01 | 0.149 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.092723e-01 | 0.149 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.092723e-01 | 0.149 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.095010e-01 | 0.149 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 7.096701e-01 | 0.149 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.096701e-01 | 0.149 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.096701e-01 | 0.149 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 7.096701e-01 | 0.149 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.096701e-01 | 0.149 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.096701e-01 | 0.149 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.096701e-01 | 0.149 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.096701e-01 | 0.149 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.096701e-01 | 0.149 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.121255e-01 | 0.147 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.121255e-01 | 0.147 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.121391e-01 | 0.147 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.121391e-01 | 0.147 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.131653e-01 | 0.147 | 1 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.136849e-01 | 0.146 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.136849e-01 | 0.146 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.136849e-01 | 0.146 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.198093e-01 | 0.143 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.203005e-01 | 0.142 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.265705e-01 | 0.139 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.279461e-01 | 0.138 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.279461e-01 | 0.138 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.279461e-01 | 0.138 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.279461e-01 | 0.138 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.279461e-01 | 0.138 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.279461e-01 | 0.138 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.279461e-01 | 0.138 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.279461e-01 | 0.138 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.279461e-01 | 0.138 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.279461e-01 | 0.138 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.279461e-01 | 0.138 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.279461e-01 | 0.138 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.279461e-01 | 0.138 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.279461e-01 | 0.138 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.279461e-01 | 0.138 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.282358e-01 | 0.138 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.290632e-01 | 0.137 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.290632e-01 | 0.137 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.309096e-01 | 0.136 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.309096e-01 | 0.136 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.309096e-01 | 0.136 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.309096e-01 | 0.136 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.323059e-01 | 0.135 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.333320e-01 | 0.135 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.333320e-01 | 0.135 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.333320e-01 | 0.135 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.333320e-01 | 0.135 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.333320e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.337150e-01 | 0.134 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.337150e-01 | 0.134 | 1 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.351716e-01 | 0.134 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 7.351716e-01 | 0.134 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.351716e-01 | 0.134 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.384314e-01 | 0.132 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.400398e-01 | 0.131 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.400398e-01 | 0.131 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.404484e-01 | 0.131 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.432518e-01 | 0.129 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.473447e-01 | 0.126 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.473447e-01 | 0.126 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.474164e-01 | 0.126 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.477795e-01 | 0.126 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.489394e-01 | 0.126 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.499103e-01 | 0.125 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.499103e-01 | 0.125 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.553312e-01 | 0.122 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.553312e-01 | 0.122 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.553312e-01 | 0.122 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.553312e-01 | 0.122 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.583199e-01 | 0.120 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.583199e-01 | 0.120 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.583199e-01 | 0.120 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.583199e-01 | 0.120 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.583199e-01 | 0.120 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.583199e-01 | 0.120 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.583199e-01 | 0.120 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.583199e-01 | 0.120 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.583199e-01 | 0.120 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.583199e-01 | 0.120 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.583199e-01 | 0.120 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.583199e-01 | 0.120 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.583199e-01 | 0.120 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.583199e-01 | 0.120 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.583199e-01 | 0.120 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.583199e-01 | 0.120 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.583199e-01 | 0.120 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.586369e-01 | 0.120 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.630004e-01 | 0.117 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.636519e-01 | 0.117 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.636519e-01 | 0.117 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.642231e-01 | 0.117 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.654458e-01 | 0.116 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.654458e-01 | 0.116 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.654458e-01 | 0.116 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.668118e-01 | 0.115 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.668118e-01 | 0.115 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.720703e-01 | 0.112 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 7.742478e-01 | 0.111 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.757441e-01 | 0.110 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.757441e-01 | 0.110 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.771331e-01 | 0.110 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.775380e-01 | 0.109 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.775380e-01 | 0.109 | 1 | 1 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.778899e-01 | 0.109 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.778899e-01 | 0.109 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.820912e-01 | 0.107 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.820912e-01 | 0.107 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.853042e-01 | 0.105 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.853042e-01 | 0.105 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.853042e-01 | 0.105 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.853042e-01 | 0.105 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.853042e-01 | 0.105 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.853042e-01 | 0.105 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.853042e-01 | 0.105 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.853042e-01 | 0.105 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.853042e-01 | 0.105 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 7.853042e-01 | 0.105 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.853042e-01 | 0.105 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.853042e-01 | 0.105 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.904431e-01 | 0.102 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.930325e-01 | 0.101 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.933790e-01 | 0.101 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.946505e-01 | 0.100 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.946505e-01 | 0.100 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.977483e-01 | 0.098 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.977483e-01 | 0.098 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.977483e-01 | 0.098 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.024803e-01 | 0.096 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.024803e-01 | 0.096 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.024889e-01 | 0.096 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.036375e-01 | 0.095 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.054361e-01 | 0.094 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.054361e-01 | 0.094 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.054361e-01 | 0.094 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.054361e-01 | 0.094 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.092771e-01 | 0.092 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.092771e-01 | 0.092 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.092771e-01 | 0.092 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.092771e-01 | 0.092 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.092771e-01 | 0.092 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.092771e-01 | 0.092 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.092771e-01 | 0.092 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.092771e-01 | 0.092 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.092771e-01 | 0.092 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 8.092771e-01 | 0.092 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.092771e-01 | 0.092 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.092771e-01 | 0.092 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.092771e-01 | 0.092 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.112982e-01 | 0.091 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.115539e-01 | 0.091 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.120957e-01 | 0.090 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.121323e-01 | 0.090 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.121323e-01 | 0.090 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 8.121323e-01 | 0.090 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.121323e-01 | 0.090 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.121323e-01 | 0.090 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.121323e-01 | 0.090 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.121323e-01 | 0.090 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.121323e-01 | 0.090 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.124522e-01 | 0.090 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.124522e-01 | 0.090 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.144154e-01 | 0.089 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.179093e-01 | 0.087 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.181314e-01 | 0.087 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.181314e-01 | 0.087 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.181314e-01 | 0.087 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.214922e-01 | 0.085 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.235913e-01 | 0.084 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.235913e-01 | 0.084 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.238073e-01 | 0.084 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.244358e-01 | 0.084 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.255703e-01 | 0.083 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.262402e-01 | 0.083 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.282719e-01 | 0.082 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.282719e-01 | 0.082 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.282719e-01 | 0.082 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 8.282719e-01 | 0.082 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.282719e-01 | 0.082 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.301365e-01 | 0.081 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.301365e-01 | 0.081 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.301365e-01 | 0.081 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.301365e-01 | 0.081 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.301365e-01 | 0.081 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.301365e-01 | 0.081 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.301365e-01 | 0.081 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.301365e-01 | 0.081 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.305743e-01 | 0.081 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.305743e-01 | 0.081 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 8.305743e-01 | 0.081 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.305743e-01 | 0.081 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.305743e-01 | 0.081 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.305743e-01 | 0.081 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.305743e-01 | 0.081 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 8.305743e-01 | 0.081 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.305743e-01 | 0.081 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.414745e-01 | 0.075 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.426118e-01 | 0.074 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.431510e-01 | 0.074 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.431510e-01 | 0.074 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.431510e-01 | 0.074 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.431510e-01 | 0.074 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.431510e-01 | 0.074 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.432619e-01 | 0.074 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.432619e-01 | 0.074 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.432619e-01 | 0.074 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.463531e-01 | 0.072 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.463531e-01 | 0.072 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.494945e-01 | 0.071 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.494945e-01 | 0.071 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.494945e-01 | 0.071 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.494945e-01 | 0.071 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.494945e-01 | 0.071 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.494945e-01 | 0.071 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.494945e-01 | 0.071 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.494945e-01 | 0.071 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.494945e-01 | 0.071 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.494945e-01 | 0.071 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.494945e-01 | 0.071 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.494945e-01 | 0.071 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.494945e-01 | 0.071 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.494945e-01 | 0.071 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.494945e-01 | 0.071 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.494945e-01 | 0.071 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.494945e-01 | 0.071 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.504960e-01 | 0.070 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.509604e-01 | 0.070 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.509606e-01 | 0.070 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.512234e-01 | 0.070 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.512234e-01 | 0.070 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.512234e-01 | 0.070 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.521691e-01 | 0.069 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.559146e-01 | 0.068 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.559146e-01 | 0.068 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.568497e-01 | 0.067 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.568497e-01 | 0.067 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.568497e-01 | 0.067 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.580471e-01 | 0.066 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.586924e-01 | 0.066 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.609356e-01 | 0.065 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.614396e-01 | 0.065 | 1 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.620315e-01 | 0.064 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.622451e-01 | 0.064 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.624979e-01 | 0.064 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.636306e-01 | 0.064 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.648635e-01 | 0.063 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.663029e-01 | 0.062 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.663029e-01 | 0.062 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.663029e-01 | 0.062 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.663029e-01 | 0.062 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 8.663029e-01 | 0.062 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 8.663029e-01 | 0.062 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.663029e-01 | 0.062 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.663029e-01 | 0.062 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.663029e-01 | 0.062 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.663029e-01 | 0.062 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.663029e-01 | 0.062 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.663029e-01 | 0.062 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.663029e-01 | 0.062 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.663029e-01 | 0.062 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.663029e-01 | 0.062 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.663029e-01 | 0.062 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.663029e-01 | 0.062 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.665187e-01 | 0.062 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.694461e-01 | 0.061 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.694461e-01 | 0.061 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.694461e-01 | 0.061 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.714154e-01 | 0.060 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.717273e-01 | 0.060 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.717273e-01 | 0.060 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.717273e-01 | 0.060 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.722990e-01 | 0.059 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.730141e-01 | 0.059 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.735494e-01 | 0.059 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.735494e-01 | 0.059 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.737044e-01 | 0.059 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.739854e-01 | 0.058 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.771765e-01 | 0.057 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.806410e-01 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.806410e-01 | 0.055 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.810155e-01 | 0.055 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.811029e-01 | 0.055 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.812349e-01 | 0.055 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.812349e-01 | 0.055 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.812349e-01 | 0.055 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.812349e-01 | 0.055 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.812349e-01 | 0.055 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.812349e-01 | 0.055 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.812349e-01 | 0.055 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.812349e-01 | 0.055 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.812349e-01 | 0.055 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.812349e-01 | 0.055 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.828116e-01 | 0.054 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.839877e-01 | 0.054 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 8.843602e-01 | 0.053 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.846257e-01 | 0.053 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.882361e-01 | 0.051 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.882361e-01 | 0.051 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.893178e-01 | 0.051 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.893178e-01 | 0.051 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.903724e-01 | 0.050 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.905158e-01 | 0.050 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.913060e-01 | 0.050 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.916301e-01 | 0.050 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.916301e-01 | 0.050 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.916301e-01 | 0.050 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.916301e-01 | 0.050 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.916301e-01 | 0.050 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.919294e-01 | 0.050 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.919294e-01 | 0.050 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.945001e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.945001e-01 | 0.048 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.945001e-01 | 0.048 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.945001e-01 | 0.048 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.945001e-01 | 0.048 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.945001e-01 | 0.048 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.945001e-01 | 0.048 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.945001e-01 | 0.048 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.945001e-01 | 0.048 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.945001e-01 | 0.048 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.945001e-01 | 0.048 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 8.945001e-01 | 0.048 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.945001e-01 | 0.048 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.945001e-01 | 0.048 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.945001e-01 | 0.048 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.949730e-01 | 0.048 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.965470e-01 | 0.047 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.013588e-01 | 0.045 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.013588e-01 | 0.045 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.013588e-01 | 0.045 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.013588e-01 | 0.045 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.013588e-01 | 0.045 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.040510e-01 | 0.044 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 9.042225e-01 | 0.044 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.062843e-01 | 0.043 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.062843e-01 | 0.043 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.062843e-01 | 0.043 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.062843e-01 | 0.043 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.062843e-01 | 0.043 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.062843e-01 | 0.043 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.062843e-01 | 0.043 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.062843e-01 | 0.043 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 9.062843e-01 | 0.043 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 9.062843e-01 | 0.043 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.062843e-01 | 0.043 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.082770e-01 | 0.042 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.082770e-01 | 0.042 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.118315e-01 | 0.040 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.140511e-01 | 0.039 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.158300e-01 | 0.038 | 1 | 1 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.167528e-01 | 0.038 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.167528e-01 | 0.038 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.167528e-01 | 0.038 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.167528e-01 | 0.038 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 9.167528e-01 | 0.038 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.167528e-01 | 0.038 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.167528e-01 | 0.038 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.167528e-01 | 0.038 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.167528e-01 | 0.038 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.167528e-01 | 0.038 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.167528e-01 | 0.038 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.168640e-01 | 0.038 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.184166e-01 | 0.037 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.184166e-01 | 0.037 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.207765e-01 | 0.036 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.223492e-01 | 0.035 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.243396e-01 | 0.034 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.258659e-01 | 0.033 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.260525e-01 | 0.033 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.260525e-01 | 0.033 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.260525e-01 | 0.033 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.260525e-01 | 0.033 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.260525e-01 | 0.033 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.260525e-01 | 0.033 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.260525e-01 | 0.033 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.262621e-01 | 0.033 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.268572e-01 | 0.033 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.268572e-01 | 0.033 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.280102e-01 | 0.032 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.284563e-01 | 0.032 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.284563e-01 | 0.032 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.284563e-01 | 0.032 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.292064e-01 | 0.032 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.310064e-01 | 0.031 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 9.311160e-01 | 0.031 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.326695e-01 | 0.030 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.326695e-01 | 0.030 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.326695e-01 | 0.030 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.326695e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.343138e-01 | 0.030 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.343138e-01 | 0.030 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.343138e-01 | 0.030 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.343138e-01 | 0.030 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.343138e-01 | 0.030 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.344186e-01 | 0.029 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.354670e-01 | 0.029 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.354789e-01 | 0.029 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.358489e-01 | 0.029 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.371245e-01 | 0.028 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.388788e-01 | 0.027 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.393476e-01 | 0.027 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.397814e-01 | 0.027 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.416526e-01 | 0.026 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.416526e-01 | 0.026 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.416526e-01 | 0.026 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.416526e-01 | 0.026 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.416526e-01 | 0.026 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.416526e-01 | 0.026 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.416526e-01 | 0.026 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.416526e-01 | 0.026 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.416526e-01 | 0.026 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.422512e-01 | 0.026 | 1 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.432353e-01 | 0.025 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.439057e-01 | 0.025 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.445416e-01 | 0.025 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.445416e-01 | 0.025 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.447354e-01 | 0.025 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.447354e-01 | 0.025 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.481718e-01 | 0.023 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.481718e-01 | 0.023 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.481718e-01 | 0.023 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.481718e-01 | 0.023 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.481718e-01 | 0.023 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.481718e-01 | 0.023 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.497025e-01 | 0.022 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.497025e-01 | 0.022 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 9.497025e-01 | 0.022 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.497025e-01 | 0.022 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.520953e-01 | 0.021 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.535267e-01 | 0.021 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.535267e-01 | 0.021 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.535267e-01 | 0.021 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.539630e-01 | 0.020 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.539630e-01 | 0.020 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.539630e-01 | 0.020 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.539630e-01 | 0.020 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.539630e-01 | 0.020 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.539630e-01 | 0.020 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.539630e-01 | 0.020 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.544029e-01 | 0.020 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.544029e-01 | 0.020 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.544029e-01 | 0.020 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.544029e-01 | 0.020 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.545890e-01 | 0.020 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.557639e-01 | 0.020 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.560049e-01 | 0.020 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.572865e-01 | 0.019 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.574149e-01 | 0.019 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.574852e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.586812e-01 | 0.018 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.591074e-01 | 0.018 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.591074e-01 | 0.018 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.591670e-01 | 0.018 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.591716e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.591716e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.591716e-01 | 0.018 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.591716e-01 | 0.018 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.591716e-01 | 0.018 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.591716e-01 | 0.018 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.591716e-01 | 0.018 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.598558e-01 | 0.018 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.609068e-01 | 0.017 | 1 | 0 |
| Collagen formation | R-HSA-1474290 | 9.617888e-01 | 0.017 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.625730e-01 | 0.017 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.625730e-01 | 0.017 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.625730e-01 | 0.017 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.625730e-01 | 0.017 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.636772e-01 | 0.016 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.636772e-01 | 0.016 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.636772e-01 | 0.016 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.636772e-01 | 0.016 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.636772e-01 | 0.016 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.642828e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.647975e-01 | 0.016 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.652693e-01 | 0.015 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.661114e-01 | 0.015 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.661114e-01 | 0.015 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.661114e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.661114e-01 | 0.015 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.661114e-01 | 0.015 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.674467e-01 | 0.014 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.677365e-01 | 0.014 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.677365e-01 | 0.014 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.677365e-01 | 0.014 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.677365e-01 | 0.014 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.677365e-01 | 0.014 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.677365e-01 | 0.014 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.677365e-01 | 0.014 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.677365e-01 | 0.014 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.681210e-01 | 0.014 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.700918e-01 | 0.013 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.701149e-01 | 0.013 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.701149e-01 | 0.013 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.713424e-01 | 0.013 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.713424e-01 | 0.013 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.713424e-01 | 0.013 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.713424e-01 | 0.013 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.713424e-01 | 0.013 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.713424e-01 | 0.013 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.714084e-01 | 0.013 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.720503e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.732614e-01 | 0.012 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.741506e-01 | 0.011 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.741506e-01 | 0.011 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.745455e-01 | 0.011 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.745455e-01 | 0.011 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.745455e-01 | 0.011 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.745455e-01 | 0.011 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.748974e-01 | 0.011 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.763815e-01 | 0.010 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.764242e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.770024e-01 | 0.010 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.773025e-01 | 0.010 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.773908e-01 | 0.010 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.773908e-01 | 0.010 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.773908e-01 | 0.010 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.783336e-01 | 0.010 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.788492e-01 | 0.009 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.791703e-01 | 0.009 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.799181e-01 | 0.009 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.799181e-01 | 0.009 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.799181e-01 | 0.009 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.799181e-01 | 0.009 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.807660e-01 | 0.008 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.821631e-01 | 0.008 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.821631e-01 | 0.008 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.821631e-01 | 0.008 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.832530e-01 | 0.007 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.835854e-01 | 0.007 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.838806e-01 | 0.007 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.841572e-01 | 0.007 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.841572e-01 | 0.007 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.841572e-01 | 0.007 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.841572e-01 | 0.007 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.845972e-01 | 0.007 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.848193e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.848761e-01 | 0.007 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.849270e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.852325e-01 | 0.006 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.859285e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.859285e-01 | 0.006 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.868477e-01 | 0.006 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.868477e-01 | 0.006 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.875018e-01 | 0.005 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.875018e-01 | 0.005 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.875018e-01 | 0.005 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.875018e-01 | 0.005 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.876215e-01 | 0.005 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.880158e-01 | 0.005 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.888793e-01 | 0.005 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.888993e-01 | 0.005 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.888993e-01 | 0.005 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.893214e-01 | 0.005 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.899678e-01 | 0.004 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.905170e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.908652e-01 | 0.004 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.909521e-01 | 0.004 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.909521e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.910304e-01 | 0.004 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.912432e-01 | 0.004 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.912432e-01 | 0.004 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.918609e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.921626e-01 | 0.003 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.922225e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.922225e-01 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.922225e-01 | 0.003 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.922225e-01 | 0.003 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.922225e-01 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.922225e-01 | 0.003 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.924293e-01 | 0.003 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.926456e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.928629e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.928751e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.930924e-01 | 0.003 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.930924e-01 | 0.003 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.930924e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.930924e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.931864e-01 | 0.003 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.931864e-01 | 0.003 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.932257e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.934771e-01 | 0.003 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.938048e-01 | 0.003 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.938650e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.938650e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.939984e-01 | 0.003 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.940276e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.945512e-01 | 0.002 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.945512e-01 | 0.002 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.945512e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.948826e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.948826e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.950136e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.950136e-01 | 0.002 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.951540e-01 | 0.002 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.951607e-01 | 0.002 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.951607e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.951607e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.953509e-01 | 0.002 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.953509e-01 | 0.002 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.956362e-01 | 0.002 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.957021e-01 | 0.002 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.957021e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.957021e-01 | 0.002 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.957021e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.959708e-01 | 0.002 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.960712e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.960712e-01 | 0.002 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.961829e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.961829e-01 | 0.002 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.961829e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.961829e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.961829e-01 | 0.002 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.961829e-01 | 0.002 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.964635e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.966100e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.966100e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.966164e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.968172e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.968411e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.971361e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.971361e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.971361e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.972387e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.972433e-01 | 0.001 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.973262e-01 | 0.001 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.973262e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.973262e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.974235e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.976254e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.976254e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.978911e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.978911e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.981271e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.981308e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.982301e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.983368e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.983370e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.984854e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.985229e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.985906e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.986883e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.986883e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.987767e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.988351e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.989354e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.989655e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.990258e-01 | 0.000 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.990813e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.991131e-01 | 0.000 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.991386e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.992034e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.992514e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992847e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.993577e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.993641e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.993737e-01 | 0.000 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.994287e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.994328e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.994579e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.994927e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.995831e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.995831e-01 | 0.000 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.995914e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.996259e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.996259e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.996448e-01 | 0.000 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.996644e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.996989e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997064e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997199e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.997391e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.997640e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.997791e-01 | 0.000 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.997933e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.998039e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.998039e-01 | 0.000 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.998103e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.998259e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998359e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.998596e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.998627e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.998686e-01 | 0.000 | 1 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998849e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999147e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999242e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999321e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999327e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999329e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999470e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999571e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999581e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999581e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999625e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999632e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999664e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999713e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999740e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999766e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999807e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999818e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999857e-01 | 0.000 | 1 | 0 |
| Translation | R-HSA-72766 | 9.999897e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999900e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999911e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999921e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999951e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999975e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999979e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999981e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999994e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999995e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999995e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999995e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999995e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 2.793654e-12 | 11.554 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.004896e-11 | 10.998 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.414369e-11 | 10.193 | 1 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.801710e-10 | 9.744 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.733070e-10 | 9.761 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.031527e-10 | 9.692 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.725797e-10 | 9.565 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.065340e-10 | 9.391 | 1 | 0 |
| M Phase | R-HSA-68886 | 4.785994e-10 | 9.320 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.111626e-10 | 9.291 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.167593e-09 | 8.933 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.756884e-09 | 8.755 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.086890e-09 | 8.681 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.448128e-09 | 8.462 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.722444e-09 | 8.429 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.028508e-09 | 8.299 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.935753e-09 | 8.100 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.397462e-09 | 8.076 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.501374e-08 | 7.824 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.196171e-08 | 7.658 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.621607e-08 | 7.581 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.603323e-08 | 7.252 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.853959e-08 | 7.233 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.859218e-08 | 7.164 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.481556e-08 | 7.126 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.983042e-08 | 7.098 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.122304e-08 | 7.040 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.787329e-08 | 7.009 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.919553e-08 | 7.004 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.733320e-08 | 7.012 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.225839e-07 | 6.912 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.273346e-07 | 6.895 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.569082e-07 | 6.804 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.715704e-07 | 6.766 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.346114e-07 | 6.630 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.386122e-07 | 6.622 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.697271e-07 | 6.569 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.484800e-07 | 6.348 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.854833e-07 | 6.314 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.916428e-07 | 6.308 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.175679e-07 | 6.286 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.085629e-07 | 6.294 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.113221e-07 | 6.214 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.650313e-07 | 6.177 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.534508e-07 | 6.069 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.056856e-07 | 6.043 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.320928e-07 | 6.031 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 9.769678e-07 | 6.010 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.105903e-06 | 5.956 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.137905e-06 | 5.944 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.177095e-06 | 5.929 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.218021e-06 | 5.914 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.177095e-06 | 5.929 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.244104e-06 | 5.905 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.454838e-06 | 5.837 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.454838e-06 | 5.837 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.400971e-06 | 5.854 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.535772e-06 | 5.814 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.549598e-06 | 5.810 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.742656e-06 | 5.759 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.804570e-06 | 5.744 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.058072e-06 | 5.687 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.077216e-06 | 5.683 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.153786e-06 | 5.667 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.839501e-06 | 5.547 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.040164e-06 | 5.517 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.396828e-06 | 5.469 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.602464e-06 | 5.443 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.129996e-06 | 5.384 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.085192e-06 | 5.294 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.158826e-06 | 5.287 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.657288e-06 | 5.247 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.657288e-06 | 5.247 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.278303e-06 | 5.202 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.226252e-06 | 5.206 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.771178e-06 | 5.169 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.864570e-06 | 5.163 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 6.864570e-06 | 5.163 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.312789e-06 | 5.136 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.933340e-06 | 5.159 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.014593e-05 | 4.994 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.123531e-05 | 4.949 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.296052e-05 | 4.887 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.313868e-05 | 4.881 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.633351e-05 | 4.787 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.943737e-05 | 4.711 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.952101e-05 | 4.709 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.952101e-05 | 4.709 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.007929e-05 | 4.697 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.237705e-05 | 4.650 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.389632e-05 | 4.622 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.769275e-05 | 4.558 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.790652e-05 | 4.554 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.792518e-05 | 4.554 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.998058e-05 | 4.523 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.287942e-05 | 4.483 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.924791e-05 | 4.406 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.924791e-05 | 4.406 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.730368e-05 | 4.428 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.672213e-05 | 4.435 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.901171e-05 | 4.409 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.122698e-05 | 4.385 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.631965e-05 | 4.334 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.631965e-05 | 4.334 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.826854e-05 | 4.316 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.120967e-05 | 4.291 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.453430e-05 | 4.263 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.699728e-05 | 4.244 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.408968e-05 | 4.267 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.528414e-05 | 4.185 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.266327e-05 | 4.139 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.908303e-05 | 4.102 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.994579e-05 | 4.097 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.708536e-05 | 4.060 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.022280e-04 | 3.990 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.533413e-05 | 4.021 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.079770e-04 | 3.967 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.216847e-04 | 3.915 | 1 | 1 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.549090e-04 | 3.810 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.549090e-04 | 3.810 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.563049e-04 | 3.806 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.573734e-04 | 3.803 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.625333e-04 | 3.789 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.749373e-04 | 3.757 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.787674e-04 | 3.748 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.327143e-04 | 3.633 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.529427e-04 | 3.597 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.356512e-04 | 3.628 | 1 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.940726e-04 | 3.532 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.055450e-04 | 3.515 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.086124e-04 | 3.511 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.141705e-04 | 3.503 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.230946e-04 | 3.491 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.282449e-04 | 3.484 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.307773e-04 | 3.480 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.612690e-04 | 3.442 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.424975e-04 | 3.354 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.248236e-04 | 3.372 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.916823e-04 | 3.308 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.002203e-04 | 3.301 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.080222e-04 | 3.294 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.783504e-04 | 3.238 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.939876e-04 | 3.159 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.098821e-04 | 3.149 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.240612e-04 | 3.140 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.926660e-04 | 3.049 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.360782e-04 | 3.029 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.418291e-04 | 3.026 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.720190e-04 | 3.012 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.031794e-03 | 2.986 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.064375e-03 | 2.973 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.066829e-03 | 2.972 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.098599e-03 | 2.959 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.099397e-03 | 2.959 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.199653e-03 | 2.921 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.203563e-03 | 2.920 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.490955e-03 | 2.827 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.490955e-03 | 2.827 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.480823e-03 | 2.829 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.480823e-03 | 2.829 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.368507e-03 | 2.864 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.490955e-03 | 2.827 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.384610e-03 | 2.859 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.515723e-03 | 2.819 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.562299e-03 | 2.806 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.617341e-03 | 2.791 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.700597e-03 | 2.769 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.920799e-03 | 2.717 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.134413e-03 | 2.671 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.134413e-03 | 2.671 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.134413e-03 | 2.671 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.161484e-03 | 2.665 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.398279e-03 | 2.620 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.573868e-03 | 2.589 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.581506e-03 | 2.588 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.596472e-03 | 2.586 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.900619e-03 | 2.538 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.690977e-03 | 2.570 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.616880e-03 | 2.582 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.926768e-03 | 2.534 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.749345e-03 | 2.561 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.926768e-03 | 2.534 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.764482e-03 | 2.558 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.926768e-03 | 2.534 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.884897e-03 | 2.540 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.961602e-03 | 2.528 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.963939e-03 | 2.528 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.022665e-03 | 2.520 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.032604e-03 | 2.518 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.189228e-03 | 2.496 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.282157e-03 | 2.484 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.287568e-03 | 2.483 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.388593e-03 | 2.470 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 3.391341e-03 | 2.470 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.541411e-03 | 2.451 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.842644e-03 | 2.415 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.920654e-03 | 2.407 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.129505e-03 | 2.384 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.150047e-03 | 2.382 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.263993e-03 | 2.370 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.367096e-03 | 2.360 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.396306e-03 | 2.357 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.396306e-03 | 2.357 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.246466e-03 | 2.280 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.246466e-03 | 2.280 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.246466e-03 | 2.280 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.246466e-03 | 2.280 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.144658e-03 | 2.289 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.224233e-03 | 2.282 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.596425e-03 | 2.338 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.056998e-03 | 2.296 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.888418e-03 | 2.311 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.144658e-03 | 2.289 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.090579e-03 | 2.293 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.771631e-03 | 2.321 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.865275e-03 | 2.313 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.874416e-03 | 2.312 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.224233e-03 | 2.282 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.317244e-03 | 2.274 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.405737e-03 | 2.267 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.405737e-03 | 2.267 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.410318e-03 | 2.267 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.460484e-03 | 2.263 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.460484e-03 | 2.263 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.571086e-03 | 2.254 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.571086e-03 | 2.254 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.628420e-03 | 2.250 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.787245e-03 | 2.238 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 5.787245e-03 | 2.238 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.787245e-03 | 2.238 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.787245e-03 | 2.238 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.108209e-03 | 2.214 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.108209e-03 | 2.214 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.296667e-03 | 2.201 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.426726e-03 | 2.192 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.581767e-03 | 2.182 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.581767e-03 | 2.182 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.627660e-03 | 2.179 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.627660e-03 | 2.179 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.821691e-03 | 2.107 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.057166e-03 | 2.094 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.057166e-03 | 2.094 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.038780e-03 | 2.095 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.317490e-03 | 2.136 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.098918e-03 | 2.092 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.398414e-03 | 2.076 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.434210e-03 | 2.129 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.698829e-03 | 2.061 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.698829e-03 | 2.061 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.698829e-03 | 2.061 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.773923e-03 | 2.057 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.773923e-03 | 2.057 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.817437e-03 | 2.055 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.830240e-03 | 2.054 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.830240e-03 | 2.054 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.913086e-03 | 2.050 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.963105e-03 | 2.048 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.000882e-03 | 2.046 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 9.196737e-03 | 2.036 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.620419e-03 | 2.017 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.762796e-03 | 2.010 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.762796e-03 | 2.010 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.811709e-03 | 2.008 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.871192e-03 | 2.006 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.932001e-03 | 2.003 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.932001e-03 | 2.003 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.048514e-02 | 1.979 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.059879e-02 | 1.975 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.089722e-02 | 1.963 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.118535e-02 | 1.951 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.124731e-02 | 1.949 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.154820e-02 | 1.937 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.189511e-02 | 1.925 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.203386e-02 | 1.920 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.291513e-02 | 1.889 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.291513e-02 | 1.889 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.319552e-02 | 1.880 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.319552e-02 | 1.880 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.319552e-02 | 1.880 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.319552e-02 | 1.880 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.319552e-02 | 1.880 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.328309e-02 | 1.877 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.582121e-02 | 1.801 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.571442e-02 | 1.804 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 1.645039e-02 | 1.784 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.622455e-02 | 1.790 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.667614e-02 | 1.778 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.335226e-02 | 1.874 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 1.561213e-02 | 1.807 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 1.561213e-02 | 1.807 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.625592e-02 | 1.789 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.357899e-02 | 1.867 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.448941e-02 | 1.839 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.494316e-02 | 1.826 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 1.582121e-02 | 1.801 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.582121e-02 | 1.801 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.582121e-02 | 1.801 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.404330e-02 | 1.853 | 1 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.571442e-02 | 1.804 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.571442e-02 | 1.804 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.350785e-02 | 1.869 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.592731e-02 | 1.798 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.582121e-02 | 1.801 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.606281e-02 | 1.794 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.692031e-02 | 1.772 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.761984e-02 | 1.754 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.796017e-02 | 1.746 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.867449e-02 | 1.729 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.890742e-02 | 1.723 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.890742e-02 | 1.723 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.890742e-02 | 1.723 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.901676e-02 | 1.721 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.982315e-02 | 1.703 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.992924e-02 | 1.701 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.049313e-02 | 1.688 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.049313e-02 | 1.688 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.049313e-02 | 1.688 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.049313e-02 | 1.688 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.049313e-02 | 1.688 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.086467e-02 | 1.681 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 2.086467e-02 | 1.681 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.097232e-02 | 1.678 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.097232e-02 | 1.678 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.097232e-02 | 1.678 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.097232e-02 | 1.678 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.137796e-02 | 1.670 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.169032e-02 | 1.664 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.239682e-02 | 1.650 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.251668e-02 | 1.647 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.328928e-02 | 1.633 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.431050e-02 | 1.614 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.434715e-02 | 1.614 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.512595e-02 | 1.600 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.553355e-02 | 1.593 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.553355e-02 | 1.593 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 2.553355e-02 | 1.593 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.553355e-02 | 1.593 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.266752e-02 | 1.486 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.266752e-02 | 1.486 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 3.082255e-02 | 1.511 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.759356e-02 | 1.559 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.824515e-02 | 1.549 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.930566e-02 | 1.533 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.415025e-02 | 1.467 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.580747e-02 | 1.588 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.968422e-02 | 1.527 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.302678e-02 | 1.481 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.806669e-02 | 1.552 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.765884e-02 | 1.558 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.106327e-02 | 1.508 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.657975e-02 | 1.575 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.020284e-02 | 1.520 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.047581e-02 | 1.516 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.765884e-02 | 1.558 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.617443e-02 | 1.582 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.656261e-02 | 1.576 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.082255e-02 | 1.511 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.106327e-02 | 1.508 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.106327e-02 | 1.508 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.496022e-02 | 1.456 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.603424e-02 | 1.443 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 3.675129e-02 | 1.435 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.675129e-02 | 1.435 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.773654e-02 | 1.423 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.842035e-02 | 1.415 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.873656e-02 | 1.412 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.904652e-02 | 1.408 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.910032e-02 | 1.408 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.148847e-02 | 1.382 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.203860e-02 | 1.376 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.275333e-02 | 1.369 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.333416e-02 | 1.363 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.335915e-02 | 1.363 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.351919e-02 | 1.361 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.628029e-02 | 1.335 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.680233e-02 | 1.330 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.680233e-02 | 1.330 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.704073e-02 | 1.328 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.718825e-02 | 1.326 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.721968e-02 | 1.326 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.743617e-02 | 1.324 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.771168e-02 | 1.321 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.868997e-02 | 1.313 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.868997e-02 | 1.313 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.058031e-02 | 1.296 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.058031e-02 | 1.296 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.069780e-02 | 1.295 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.098271e-02 | 1.293 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.098271e-02 | 1.293 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.098271e-02 | 1.293 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.098271e-02 | 1.293 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.343377e-02 | 1.272 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.365277e-02 | 1.270 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.365277e-02 | 1.270 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.388480e-02 | 1.269 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.388480e-02 | 1.269 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.441940e-02 | 1.264 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.441940e-02 | 1.264 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.441940e-02 | 1.264 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.639157e-02 | 1.249 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.639157e-02 | 1.249 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.670146e-02 | 1.246 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.849374e-02 | 1.233 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.849374e-02 | 1.233 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.849374e-02 | 1.233 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 5.873601e-02 | 1.231 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.877428e-02 | 1.231 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.887068e-02 | 1.230 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.915365e-02 | 1.228 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.938026e-02 | 1.226 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.083905e-02 | 1.216 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.083905e-02 | 1.216 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.132257e-02 | 1.212 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.371750e-02 | 1.196 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.371750e-02 | 1.196 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.371750e-02 | 1.196 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.371750e-02 | 1.196 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.464414e-02 | 1.189 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.464414e-02 | 1.189 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.640926e-02 | 1.178 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.709200e-02 | 1.173 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.709200e-02 | 1.173 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.709200e-02 | 1.173 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.709200e-02 | 1.173 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.709200e-02 | 1.173 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 6.794497e-02 | 1.168 | 1 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 9.508297e-02 | 1.022 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 9.508297e-02 | 1.022 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.031858e-01 | 0.986 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.031858e-01 | 0.986 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.031858e-01 | 0.986 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.347829e-02 | 1.078 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.610992e-02 | 1.017 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.673094e-02 | 1.014 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.626930e-02 | 1.118 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.626930e-02 | 1.118 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.626930e-02 | 1.118 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.626930e-02 | 1.118 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.474102e-02 | 1.072 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.474102e-02 | 1.072 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.563969e-02 | 1.019 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.601623e-02 | 1.065 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.400388e-02 | 1.076 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.673094e-02 | 1.014 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.280758e-02 | 1.138 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.626930e-02 | 1.118 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.474102e-02 | 1.072 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.058833e-01 | 0.975 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 9.508297e-02 | 1.022 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 9.610992e-02 | 1.017 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.474102e-02 | 1.072 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.400388e-02 | 1.076 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.400388e-02 | 1.076 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.370997e-02 | 1.028 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.067336e-02 | 1.093 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.403983e-02 | 1.131 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.099602e-02 | 1.041 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.620441e-02 | 1.064 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.403983e-02 | 1.131 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.025938e-01 | 0.989 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 7.075674e-02 | 1.150 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.408016e-02 | 1.075 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.276303e-02 | 1.082 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.276303e-02 | 1.082 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.483666e-02 | 1.071 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.863739e-02 | 1.052 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.673094e-02 | 1.014 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.915741e-02 | 1.050 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.400388e-02 | 1.076 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.017593e-01 | 0.992 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.139560e-02 | 1.089 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.620441e-02 | 1.064 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.058833e-01 | 0.975 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.058833e-01 | 0.975 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.743149e-02 | 1.111 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.075674e-02 | 1.150 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.610992e-02 | 1.017 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.178065e-02 | 1.144 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.019653e-01 | 0.992 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 9.610992e-02 | 1.017 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.064163e-01 | 0.973 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.076425e-01 | 0.968 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.081043e-01 | 0.966 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.095785e-01 | 0.960 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.095785e-01 | 0.960 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.095785e-01 | 0.960 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.095785e-01 | 0.960 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.123049e-01 | 0.950 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.130573e-01 | 0.947 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.148355e-01 | 0.940 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.148355e-01 | 0.940 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.148355e-01 | 0.940 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.148355e-01 | 0.940 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.151508e-01 | 0.939 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.196151e-01 | 0.922 | 1 | 1 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.196151e-01 | 0.922 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.196151e-01 | 0.922 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.202378e-01 | 0.920 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.207892e-01 | 0.918 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.225522e-01 | 0.912 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.225522e-01 | 0.912 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.230157e-01 | 0.910 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.230157e-01 | 0.910 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.230157e-01 | 0.910 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 1.230157e-01 | 0.910 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.230157e-01 | 0.910 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.230157e-01 | 0.910 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.235041e-01 | 0.908 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.235041e-01 | 0.908 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.235041e-01 | 0.908 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.235041e-01 | 0.908 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.235041e-01 | 0.908 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.238372e-01 | 0.907 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.238372e-01 | 0.907 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.238372e-01 | 0.907 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 1.284764e-01 | 0.891 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.307023e-01 | 0.884 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.317970e-01 | 0.880 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.338778e-01 | 0.873 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 1.338778e-01 | 0.873 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.388345e-01 | 0.858 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.388345e-01 | 0.858 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.405453e-01 | 0.852 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.405453e-01 | 0.852 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.420966e-01 | 0.847 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.456390e-01 | 0.837 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.456390e-01 | 0.837 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.502860e-01 | 0.823 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.502860e-01 | 0.823 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.504970e-01 | 0.822 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.516422e-01 | 0.819 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.519522e-01 | 0.818 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.524590e-01 | 0.817 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.543670e-01 | 0.811 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.543670e-01 | 0.811 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 1.545154e-01 | 0.811 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.545154e-01 | 0.811 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.570990e-01 | 0.804 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.573378e-01 | 0.803 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.580447e-01 | 0.801 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.580447e-01 | 0.801 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.580447e-01 | 0.801 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.581471e-01 | 0.801 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.581471e-01 | 0.801 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.581471e-01 | 0.801 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.581471e-01 | 0.801 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 1.581471e-01 | 0.801 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.599764e-01 | 0.796 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.606921e-01 | 0.794 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.606921e-01 | 0.794 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.606921e-01 | 0.794 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.606921e-01 | 0.794 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 1.606921e-01 | 0.794 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.651232e-01 | 0.782 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.274438e-01 | 0.643 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 2.274438e-01 | 0.643 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.274438e-01 | 0.643 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.274438e-01 | 0.643 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.274438e-01 | 0.643 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.274438e-01 | 0.643 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.274438e-01 | 0.643 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.274438e-01 | 0.643 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.911264e-01 | 0.536 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.911264e-01 | 0.536 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 2.911264e-01 | 0.536 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 2.911264e-01 | 0.536 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.911264e-01 | 0.536 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.911264e-01 | 0.536 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 2.911264e-01 | 0.536 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.818996e-01 | 0.740 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.818996e-01 | 0.740 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 1.818996e-01 | 0.740 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.129348e-01 | 0.672 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.129348e-01 | 0.672 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.129348e-01 | 0.672 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.129348e-01 | 0.672 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.129348e-01 | 0.672 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.444144e-01 | 0.612 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.444144e-01 | 0.612 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.444144e-01 | 0.612 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.444144e-01 | 0.612 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.816433e-01 | 0.741 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.816433e-01 | 0.741 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.032710e-01 | 0.692 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.760546e-01 | 0.559 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.760546e-01 | 0.559 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.760546e-01 | 0.559 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.760546e-01 | 0.559 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.760546e-01 | 0.559 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.708221e-01 | 0.767 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.708221e-01 | 0.767 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.254515e-01 | 0.647 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.254515e-01 | 0.647 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.254515e-01 | 0.647 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.076152e-01 | 0.512 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.480660e-01 | 0.605 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.480660e-01 | 0.605 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.862902e-01 | 0.730 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.694315e-01 | 0.771 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.009972e-01 | 0.697 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.009972e-01 | 0.697 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.818987e-01 | 0.740 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.941528e-01 | 0.531 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.941528e-01 | 0.531 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.941528e-01 | 0.531 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.160800e-01 | 0.665 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 2.160800e-01 | 0.665 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.160800e-01 | 0.665 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.596261e-01 | 0.586 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.875877e-01 | 0.727 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.875877e-01 | 0.727 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.472250e-01 | 0.607 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.992648e-01 | 0.701 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.801995e-01 | 0.744 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.907100e-01 | 0.720 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.833390e-01 | 0.737 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.632297e-01 | 0.580 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.958315e-01 | 0.529 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.357956e-01 | 0.474 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.744625e-01 | 0.562 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.367851e-01 | 0.473 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.123869e-01 | 0.673 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.350399e-01 | 0.629 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.472250e-01 | 0.607 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.324508e-01 | 0.478 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.708221e-01 | 0.767 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.784160e-01 | 0.555 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.818987e-01 | 0.740 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.350399e-01 | 0.629 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.922265e-01 | 0.534 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.069631e-01 | 0.513 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.254515e-01 | 0.647 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.490210e-01 | 0.604 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.213121e-01 | 0.655 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.350399e-01 | 0.629 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.958315e-01 | 0.529 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.632125e-01 | 0.580 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 2.760546e-01 | 0.559 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.694315e-01 | 0.771 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.472250e-01 | 0.607 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.069631e-01 | 0.513 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 2.911264e-01 | 0.536 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 2.444144e-01 | 0.612 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.941528e-01 | 0.531 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.632297e-01 | 0.580 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.708221e-01 | 0.767 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.816433e-01 | 0.741 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.334043e-01 | 0.632 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.290659e-01 | 0.483 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.618195e-01 | 0.582 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.410992e-01 | 0.618 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.567291e-01 | 0.591 | 1 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.137760e-01 | 0.670 | 1 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.567291e-01 | 0.591 | 1 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.274438e-01 | 0.643 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.274438e-01 | 0.643 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.274438e-01 | 0.643 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.274438e-01 | 0.643 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.911264e-01 | 0.536 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.816433e-01 | 0.741 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.816433e-01 | 0.741 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.480660e-01 | 0.605 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.947169e-01 | 0.711 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.213121e-01 | 0.655 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.236917e-01 | 0.650 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.236917e-01 | 0.650 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.585684e-01 | 0.587 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.876789e-01 | 0.541 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.165057e-01 | 0.665 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.154593e-01 | 0.667 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.876948e-01 | 0.727 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.947169e-01 | 0.711 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.254515e-01 | 0.647 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.762019e-01 | 0.754 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 2.254515e-01 | 0.647 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.213121e-01 | 0.655 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 1.907100e-01 | 0.720 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.904501e-01 | 0.537 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.076152e-01 | 0.512 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.710018e-01 | 0.567 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.585684e-01 | 0.587 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.010397e-01 | 0.521 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.533796e-01 | 0.596 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.112162e-01 | 0.675 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.818996e-01 | 0.740 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.708221e-01 | 0.767 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.632125e-01 | 0.580 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.367851e-01 | 0.473 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.231168e-01 | 0.651 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.160800e-01 | 0.665 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.931242e-01 | 0.533 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 3.076152e-01 | 0.512 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.549813e-01 | 0.593 | 1 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.461571e-01 | 0.609 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.875877e-01 | 0.727 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.705491e-01 | 0.568 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.828688e-01 | 0.548 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.770598e-01 | 0.557 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.760546e-01 | 0.559 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 2.760546e-01 | 0.559 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.760546e-01 | 0.559 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.076152e-01 | 0.512 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.410992e-01 | 0.618 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.078628e-01 | 0.682 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.351252e-01 | 0.629 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.517408e-01 | 0.599 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.254515e-01 | 0.647 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.794270e-01 | 0.554 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.925046e-01 | 0.716 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.551357e-01 | 0.593 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.078966e-01 | 0.682 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.524984e-01 | 0.598 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.911264e-01 | 0.536 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 2.444144e-01 | 0.612 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.076152e-01 | 0.512 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.357956e-01 | 0.474 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.467555e-01 | 0.608 | 1 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.694315e-01 | 0.771 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.743782e-01 | 0.759 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.129348e-01 | 0.672 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.444144e-01 | 0.612 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.760546e-01 | 0.559 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.050728e-01 | 0.688 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.876948e-01 | 0.727 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.082838e-01 | 0.511 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.050728e-01 | 0.688 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.160800e-01 | 0.665 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.834075e-01 | 0.548 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.876948e-01 | 0.727 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.119814e-01 | 0.506 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.876948e-01 | 0.727 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.776401e-01 | 0.557 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.974110e-01 | 0.527 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.784160e-01 | 0.555 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.076152e-01 | 0.512 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.737103e-01 | 0.563 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.708221e-01 | 0.767 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.388946e-01 | 0.470 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.388946e-01 | 0.470 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.399652e-01 | 0.469 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.432843e-01 | 0.464 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.458254e-01 | 0.461 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.495630e-01 | 0.456 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.495630e-01 | 0.456 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.495630e-01 | 0.456 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.495630e-01 | 0.456 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.495630e-01 | 0.456 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.495630e-01 | 0.456 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.495630e-01 | 0.456 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 3.518207e-01 | 0.454 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 3.518207e-01 | 0.454 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.544198e-01 | 0.450 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.550801e-01 | 0.450 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.550801e-01 | 0.450 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.550801e-01 | 0.450 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.578641e-01 | 0.446 | 1 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.579559e-01 | 0.446 | 1 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.587412e-01 | 0.445 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.590978e-01 | 0.445 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.601788e-01 | 0.443 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.602296e-01 | 0.443 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.626345e-01 | 0.441 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.693428e-01 | 0.433 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.693428e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.693428e-01 | 0.433 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.693428e-01 | 0.433 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.693428e-01 | 0.433 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.697249e-01 | 0.432 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.697249e-01 | 0.432 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.697249e-01 | 0.432 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.697249e-01 | 0.432 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.697249e-01 | 0.432 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.706511e-01 | 0.431 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.706511e-01 | 0.431 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.743603e-01 | 0.427 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.794608e-01 | 0.421 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.794608e-01 | 0.421 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.814405e-01 | 0.419 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.831723e-01 | 0.417 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.870350e-01 | 0.412 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.870350e-01 | 0.412 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.870350e-01 | 0.412 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.870350e-01 | 0.412 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.878777e-01 | 0.411 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.918896e-01 | 0.407 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.962730e-01 | 0.402 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.971366e-01 | 0.401 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.971366e-01 | 0.401 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.999676e-01 | 0.398 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.999676e-01 | 0.398 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.999676e-01 | 0.398 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.999676e-01 | 0.398 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.031856e-01 | 0.394 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.031856e-01 | 0.394 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.031856e-01 | 0.394 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.031856e-01 | 0.394 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.031856e-01 | 0.394 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.031856e-01 | 0.394 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.031856e-01 | 0.394 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.041655e-01 | 0.393 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.072871e-01 | 0.390 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.099211e-01 | 0.387 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.122355e-01 | 0.385 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.122355e-01 | 0.385 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 4.127271e-01 | 0.384 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.130413e-01 | 0.384 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.130413e-01 | 0.384 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.166792e-01 | 0.380 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.218267e-01 | 0.375 | 1 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.295102e-01 | 0.367 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.295102e-01 | 0.367 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.295102e-01 | 0.367 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.295102e-01 | 0.367 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.295102e-01 | 0.367 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.295102e-01 | 0.367 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.297373e-01 | 0.367 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.317302e-01 | 0.365 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.317302e-01 | 0.365 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.317302e-01 | 0.365 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.325371e-01 | 0.364 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.325371e-01 | 0.364 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.325371e-01 | 0.364 | 0 | 0 |
| Translation | R-HSA-72766 | 4.384143e-01 | 0.358 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.422942e-01 | 0.354 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 4.433631e-01 | 0.353 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.505623e-01 | 0.346 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.505623e-01 | 0.346 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.507323e-01 | 0.346 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 4.523904e-01 | 0.344 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.523904e-01 | 0.344 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.523904e-01 | 0.344 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.523904e-01 | 0.344 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.523904e-01 | 0.344 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.523904e-01 | 0.344 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.523904e-01 | 0.344 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.523904e-01 | 0.344 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.523904e-01 | 0.344 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.523904e-01 | 0.344 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.523904e-01 | 0.344 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.523904e-01 | 0.344 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.523904e-01 | 0.344 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.523904e-01 | 0.344 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.523904e-01 | 0.344 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.523904e-01 | 0.344 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.527211e-01 | 0.344 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.548269e-01 | 0.342 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.548269e-01 | 0.342 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.572092e-01 | 0.340 | 1 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.572140e-01 | 0.340 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.582626e-01 | 0.339 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.582626e-01 | 0.339 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.582626e-01 | 0.339 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.620356e-01 | 0.335 | 1 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.620356e-01 | 0.335 | 1 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.620356e-01 | 0.335 | 1 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.679412e-01 | 0.330 | 1 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.689627e-01 | 0.329 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.691891e-01 | 0.329 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.691891e-01 | 0.329 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.691891e-01 | 0.329 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.691891e-01 | 0.329 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.691891e-01 | 0.329 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.691891e-01 | 0.329 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.720356e-01 | 0.326 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.720356e-01 | 0.326 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.729626e-01 | 0.325 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.738518e-01 | 0.324 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.767412e-01 | 0.322 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.767412e-01 | 0.322 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.791303e-01 | 0.320 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.791303e-01 | 0.320 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.794423e-01 | 0.319 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.794423e-01 | 0.319 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.856391e-01 | 0.314 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.861545e-01 | 0.313 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.861545e-01 | 0.313 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.861545e-01 | 0.313 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.875790e-01 | 0.312 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.875790e-01 | 0.312 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.875790e-01 | 0.312 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.875790e-01 | 0.312 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.952836e-01 | 0.305 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.952836e-01 | 0.305 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.952836e-01 | 0.305 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.975411e-01 | 0.303 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.975411e-01 | 0.303 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.975411e-01 | 0.303 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 4.975411e-01 | 0.303 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 4.975411e-01 | 0.303 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.975411e-01 | 0.303 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.975411e-01 | 0.303 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.975411e-01 | 0.303 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 4.975411e-01 | 0.303 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.975411e-01 | 0.303 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 4.975411e-01 | 0.303 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 4.975411e-01 | 0.303 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.975411e-01 | 0.303 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.975411e-01 | 0.303 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 4.975411e-01 | 0.303 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.975411e-01 | 0.303 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 4.975411e-01 | 0.303 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.975411e-01 | 0.303 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 4.975411e-01 | 0.303 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.975411e-01 | 0.303 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 4.975411e-01 | 0.303 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 4.975411e-01 | 0.303 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.975411e-01 | 0.303 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.982365e-01 | 0.303 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.982365e-01 | 0.303 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.982365e-01 | 0.303 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.013144e-01 | 0.300 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 5.057034e-01 | 0.296 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 5.057034e-01 | 0.296 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 5.057034e-01 | 0.296 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.057034e-01 | 0.296 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 5.057034e-01 | 0.296 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.063117e-01 | 0.296 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.104422e-01 | 0.292 | 1 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.112458e-01 | 0.291 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.131322e-01 | 0.290 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.131322e-01 | 0.290 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.131322e-01 | 0.290 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.131322e-01 | 0.290 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.131322e-01 | 0.290 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.131322e-01 | 0.290 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.131322e-01 | 0.290 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.144021e-01 | 0.289 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.192755e-01 | 0.285 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.192755e-01 | 0.285 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.192755e-01 | 0.285 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.195715e-01 | 0.284 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.215555e-01 | 0.283 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 5.235362e-01 | 0.281 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.235362e-01 | 0.281 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.269976e-01 | 0.278 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.326989e-01 | 0.274 | 1 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.389717e-01 | 0.268 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.389717e-01 | 0.268 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.389717e-01 | 0.268 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.389717e-01 | 0.268 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.389717e-01 | 0.268 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.389717e-01 | 0.268 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.389717e-01 | 0.268 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.389717e-01 | 0.268 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.389717e-01 | 0.268 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.389717e-01 | 0.268 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.389717e-01 | 0.268 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.389717e-01 | 0.268 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.389717e-01 | 0.268 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.389717e-01 | 0.268 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.391570e-01 | 0.268 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.391570e-01 | 0.268 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.391570e-01 | 0.268 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.391570e-01 | 0.268 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.398263e-01 | 0.268 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.410543e-01 | 0.267 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.410543e-01 | 0.267 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.425218e-01 | 0.266 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.549029e-01 | 0.256 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.563397e-01 | 0.255 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.578022e-01 | 0.254 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.582371e-01 | 0.253 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.582371e-01 | 0.253 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.582371e-01 | 0.253 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.585123e-01 | 0.253 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.642025e-01 | 0.249 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.642025e-01 | 0.249 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.642025e-01 | 0.249 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.653334e-01 | 0.248 | 1 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.710934e-01 | 0.243 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.750665e-01 | 0.240 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.750665e-01 | 0.240 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.750665e-01 | 0.240 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.750665e-01 | 0.240 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.769883e-01 | 0.239 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.769883e-01 | 0.239 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 5.769883e-01 | 0.239 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.769883e-01 | 0.239 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.769883e-01 | 0.239 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.769883e-01 | 0.239 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.769883e-01 | 0.239 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.769883e-01 | 0.239 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.769883e-01 | 0.239 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.769883e-01 | 0.239 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.769883e-01 | 0.239 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.793609e-01 | 0.237 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.793609e-01 | 0.237 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.882534e-01 | 0.230 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.882534e-01 | 0.230 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.882534e-01 | 0.230 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.882534e-01 | 0.230 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.882534e-01 | 0.230 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.882534e-01 | 0.230 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.882534e-01 | 0.230 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.882534e-01 | 0.230 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 5.882534e-01 | 0.230 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.915268e-01 | 0.228 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.915268e-01 | 0.228 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.915268e-01 | 0.228 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.915268e-01 | 0.228 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.915268e-01 | 0.228 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.920537e-01 | 0.228 | 1 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.920537e-01 | 0.228 | 1 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.983051e-01 | 0.223 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.983051e-01 | 0.223 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.984210e-01 | 0.223 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.076047e-01 | 0.216 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.113034e-01 | 0.214 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.113034e-01 | 0.214 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.113034e-01 | 0.214 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.113034e-01 | 0.214 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.118721e-01 | 0.213 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.118721e-01 | 0.213 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.118721e-01 | 0.213 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.118721e-01 | 0.213 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.118721e-01 | 0.213 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.118721e-01 | 0.213 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.118721e-01 | 0.213 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.118721e-01 | 0.213 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.118721e-01 | 0.213 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.118721e-01 | 0.213 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.118721e-01 | 0.213 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.118721e-01 | 0.213 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.118721e-01 | 0.213 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.118721e-01 | 0.213 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.118721e-01 | 0.213 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 6.118721e-01 | 0.213 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.118721e-01 | 0.213 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.118721e-01 | 0.213 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.200364e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.210382e-01 | 0.207 | 1 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.210382e-01 | 0.207 | 1 | 0 |
| Hemostasis | R-HSA-109582 | 6.258801e-01 | 0.204 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.333539e-01 | 0.198 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.333539e-01 | 0.198 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.333539e-01 | 0.198 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.333539e-01 | 0.198 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.333539e-01 | 0.198 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.385702e-01 | 0.195 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.385702e-01 | 0.195 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.436591e-01 | 0.191 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.438811e-01 | 0.191 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.438811e-01 | 0.191 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.438811e-01 | 0.191 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.438811e-01 | 0.191 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.438811e-01 | 0.191 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.438811e-01 | 0.191 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.438811e-01 | 0.191 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.438811e-01 | 0.191 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.438811e-01 | 0.191 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.438811e-01 | 0.191 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.438811e-01 | 0.191 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.438811e-01 | 0.191 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.438811e-01 | 0.191 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.490870e-01 | 0.188 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.495367e-01 | 0.187 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.516931e-01 | 0.186 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.516931e-01 | 0.186 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.544130e-01 | 0.184 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 6.544130e-01 | 0.184 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.544130e-01 | 0.184 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.544130e-01 | 0.184 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.678972e-01 | 0.175 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 6.678972e-01 | 0.175 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.678972e-01 | 0.175 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.678972e-01 | 0.175 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.678972e-01 | 0.175 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.683191e-01 | 0.175 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.723080e-01 | 0.172 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.729032e-01 | 0.172 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.732521e-01 | 0.172 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.732521e-01 | 0.172 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.732521e-01 | 0.172 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.732521e-01 | 0.172 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.732521e-01 | 0.172 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.732521e-01 | 0.172 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.732521e-01 | 0.172 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.732521e-01 | 0.172 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.732521e-01 | 0.172 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.732521e-01 | 0.172 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.732521e-01 | 0.172 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.732521e-01 | 0.172 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.732521e-01 | 0.172 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 6.732521e-01 | 0.172 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 6.732521e-01 | 0.172 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.732521e-01 | 0.172 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.732521e-01 | 0.172 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.732521e-01 | 0.172 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.744943e-01 | 0.171 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.744943e-01 | 0.171 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.744943e-01 | 0.171 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 6.819336e-01 | 0.166 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 6.819336e-01 | 0.166 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.824410e-01 | 0.166 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.824410e-01 | 0.166 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.843569e-01 | 0.165 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.843569e-01 | 0.165 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.887204e-01 | 0.162 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 6.936157e-01 | 0.159 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.936157e-01 | 0.159 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 6.936157e-01 | 0.159 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.001504e-01 | 0.155 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.002022e-01 | 0.155 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.002022e-01 | 0.155 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.002022e-01 | 0.155 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.002022e-01 | 0.155 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.002022e-01 | 0.155 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.002022e-01 | 0.155 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.002022e-01 | 0.155 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.002022e-01 | 0.155 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.002022e-01 | 0.155 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.002022e-01 | 0.155 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.002022e-01 | 0.155 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.066634e-01 | 0.151 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.066634e-01 | 0.151 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.066634e-01 | 0.151 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.087413e-01 | 0.150 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.087413e-01 | 0.150 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.117990e-01 | 0.148 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.117990e-01 | 0.148 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.117990e-01 | 0.148 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.130128e-01 | 0.147 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.146770e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.146770e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.146770e-01 | 0.146 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 7.173357e-01 | 0.144 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.175594e-01 | 0.144 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.197460e-01 | 0.143 | 1 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.249311e-01 | 0.140 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.249311e-01 | 0.140 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.249311e-01 | 0.140 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.249311e-01 | 0.140 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.249311e-01 | 0.140 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.249311e-01 | 0.140 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 7.249311e-01 | 0.140 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.249311e-01 | 0.140 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.249311e-01 | 0.140 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.290687e-01 | 0.137 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.338635e-01 | 0.134 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.379204e-01 | 0.132 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.405166e-01 | 0.130 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.405166e-01 | 0.130 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.426935e-01 | 0.129 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.454519e-01 | 0.128 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.454519e-01 | 0.128 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.454519e-01 | 0.128 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 7.454519e-01 | 0.128 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.454519e-01 | 0.128 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.454519e-01 | 0.128 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.457978e-01 | 0.127 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.457978e-01 | 0.127 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.462267e-01 | 0.127 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.476215e-01 | 0.126 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.476215e-01 | 0.126 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.476215e-01 | 0.126 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.476215e-01 | 0.126 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.476215e-01 | 0.126 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.476215e-01 | 0.126 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.476215e-01 | 0.126 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.476215e-01 | 0.126 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.476215e-01 | 0.126 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.476215e-01 | 0.126 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.476215e-01 | 0.126 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.476215e-01 | 0.126 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.476215e-01 | 0.126 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.511409e-01 | 0.124 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.558581e-01 | 0.122 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.573190e-01 | 0.121 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.573190e-01 | 0.121 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.609773e-01 | 0.119 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.609773e-01 | 0.119 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 7.609773e-01 | 0.119 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.609773e-01 | 0.119 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.609773e-01 | 0.119 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 7.638428e-01 | 0.117 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.667518e-01 | 0.115 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.684320e-01 | 0.114 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.684320e-01 | 0.114 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.684414e-01 | 0.114 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 7.684414e-01 | 0.114 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.684414e-01 | 0.114 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.684414e-01 | 0.114 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 7.684414e-01 | 0.114 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.684414e-01 | 0.114 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.684414e-01 | 0.114 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.684414e-01 | 0.114 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.684738e-01 | 0.114 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.684738e-01 | 0.114 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.684738e-01 | 0.114 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 7.714102e-01 | 0.113 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.756748e-01 | 0.110 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.756748e-01 | 0.110 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.756748e-01 | 0.110 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.756748e-01 | 0.110 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.774214e-01 | 0.109 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.778147e-01 | 0.109 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.786783e-01 | 0.109 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.805524e-01 | 0.108 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.839205e-01 | 0.106 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.875449e-01 | 0.104 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 7.875449e-01 | 0.104 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.875449e-01 | 0.104 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.875449e-01 | 0.104 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.875449e-01 | 0.104 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.875449e-01 | 0.104 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.875449e-01 | 0.104 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.875449e-01 | 0.104 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.875449e-01 | 0.104 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.875449e-01 | 0.104 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.875449e-01 | 0.104 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.875449e-01 | 0.104 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.895754e-01 | 0.103 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.902842e-01 | 0.102 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.921064e-01 | 0.101 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.921064e-01 | 0.101 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.921064e-01 | 0.101 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.921064e-01 | 0.101 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.967981e-01 | 0.099 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.994143e-01 | 0.097 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.027105e-01 | 0.095 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.031490e-01 | 0.095 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.050734e-01 | 0.094 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.050734e-01 | 0.094 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.050734e-01 | 0.094 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.050734e-01 | 0.094 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.050734e-01 | 0.094 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.076131e-01 | 0.093 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.089243e-01 | 0.092 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.115822e-01 | 0.091 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.136943e-01 | 0.090 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.151116e-01 | 0.089 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.151802e-01 | 0.089 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.165327e-01 | 0.088 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.172121e-01 | 0.088 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.172121e-01 | 0.088 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.189396e-01 | 0.087 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.211567e-01 | 0.086 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.211567e-01 | 0.086 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.211567e-01 | 0.086 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.211567e-01 | 0.086 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.211567e-01 | 0.086 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.268106e-01 | 0.083 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.268977e-01 | 0.083 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.268977e-01 | 0.083 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.300744e-01 | 0.081 | 1 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.333511e-01 | 0.079 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.333511e-01 | 0.079 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.348640e-01 | 0.078 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.353452e-01 | 0.078 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.359139e-01 | 0.078 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.359139e-01 | 0.078 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.359139e-01 | 0.078 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.359139e-01 | 0.078 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.359139e-01 | 0.078 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.359139e-01 | 0.078 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.378388e-01 | 0.077 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.378388e-01 | 0.077 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.451722e-01 | 0.073 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.457819e-01 | 0.073 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.458880e-01 | 0.073 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.482271e-01 | 0.071 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.482271e-01 | 0.071 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.482271e-01 | 0.071 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.494542e-01 | 0.071 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.494542e-01 | 0.071 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.494542e-01 | 0.071 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.494542e-01 | 0.071 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.494542e-01 | 0.071 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.512070e-01 | 0.070 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.580061e-01 | 0.067 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.580061e-01 | 0.067 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.580061e-01 | 0.067 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.580061e-01 | 0.067 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.580061e-01 | 0.067 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.584252e-01 | 0.066 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.618779e-01 | 0.065 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.618779e-01 | 0.065 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.618779e-01 | 0.065 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.618779e-01 | 0.065 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.618779e-01 | 0.065 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.618779e-01 | 0.065 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.657542e-01 | 0.063 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.661641e-01 | 0.062 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.661641e-01 | 0.062 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.661641e-01 | 0.062 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.672056e-01 | 0.062 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.672056e-01 | 0.062 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.706092e-01 | 0.060 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.732770e-01 | 0.059 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.732770e-01 | 0.059 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.732770e-01 | 0.059 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.732770e-01 | 0.059 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.758546e-01 | 0.058 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.758546e-01 | 0.058 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.795090e-01 | 0.056 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.817173e-01 | 0.055 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.817173e-01 | 0.055 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.837359e-01 | 0.054 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.837359e-01 | 0.054 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 8.837359e-01 | 0.054 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.837359e-01 | 0.054 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.837359e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.837359e-01 | 0.054 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.837359e-01 | 0.054 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.838876e-01 | 0.054 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.839803e-01 | 0.054 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.839812e-01 | 0.054 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.839812e-01 | 0.054 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.852782e-01 | 0.053 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.883073e-01 | 0.051 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.886174e-01 | 0.051 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.897301e-01 | 0.051 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.906882e-01 | 0.050 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.916127e-01 | 0.050 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.933323e-01 | 0.049 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.933323e-01 | 0.049 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.933323e-01 | 0.049 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.950562e-01 | 0.048 | 1 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.950810e-01 | 0.048 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.968643e-01 | 0.047 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.021027e-01 | 0.045 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.021370e-01 | 0.045 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.021370e-01 | 0.045 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.034625e-01 | 0.044 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.054950e-01 | 0.043 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.055886e-01 | 0.043 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.102155e-01 | 0.041 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.102155e-01 | 0.041 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.102155e-01 | 0.041 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.102155e-01 | 0.041 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.102155e-01 | 0.041 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.102155e-01 | 0.041 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.102155e-01 | 0.041 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.102155e-01 | 0.041 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.103202e-01 | 0.041 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.103863e-01 | 0.041 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.144544e-01 | 0.039 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.170132e-01 | 0.038 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.176276e-01 | 0.037 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.176276e-01 | 0.037 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.176276e-01 | 0.037 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.176276e-01 | 0.037 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.176276e-01 | 0.037 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.176276e-01 | 0.037 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.176276e-01 | 0.037 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.177002e-01 | 0.037 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.214641e-01 | 0.036 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.222276e-01 | 0.035 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.232317e-01 | 0.035 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.244281e-01 | 0.034 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.244281e-01 | 0.034 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.244281e-01 | 0.034 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.269692e-01 | 0.033 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.284113e-01 | 0.032 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.293747e-01 | 0.032 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.306676e-01 | 0.031 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.306676e-01 | 0.031 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.306676e-01 | 0.031 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.306676e-01 | 0.031 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.306676e-01 | 0.031 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.313259e-01 | 0.031 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.324969e-01 | 0.030 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.332593e-01 | 0.030 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.354420e-01 | 0.029 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.363923e-01 | 0.029 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.363923e-01 | 0.029 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.363923e-01 | 0.029 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.363923e-01 | 0.029 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.363923e-01 | 0.029 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.363923e-01 | 0.029 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.371987e-01 | 0.028 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.372357e-01 | 0.028 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.393294e-01 | 0.027 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.393294e-01 | 0.027 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.393294e-01 | 0.027 | 1 | 1 |
| Adaptive Immune System | R-HSA-1280218 | 9.412516e-01 | 0.026 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.416446e-01 | 0.026 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.416446e-01 | 0.026 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.416446e-01 | 0.026 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.416446e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.416446e-01 | 0.026 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.416446e-01 | 0.026 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.416446e-01 | 0.026 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.420375e-01 | 0.026 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.430528e-01 | 0.025 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.437048e-01 | 0.025 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.460037e-01 | 0.024 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.464635e-01 | 0.024 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.464635e-01 | 0.024 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.464635e-01 | 0.024 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.490429e-01 | 0.023 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.508847e-01 | 0.022 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.508847e-01 | 0.022 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.508847e-01 | 0.022 | 1 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.508847e-01 | 0.022 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.508847e-01 | 0.022 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.508847e-01 | 0.022 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.508906e-01 | 0.022 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.531735e-01 | 0.021 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.549411e-01 | 0.020 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.549411e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.549411e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.549411e-01 | 0.020 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.549411e-01 | 0.020 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.549411e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.553194e-01 | 0.020 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.569399e-01 | 0.019 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.569399e-01 | 0.019 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.572550e-01 | 0.019 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.584453e-01 | 0.018 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.584510e-01 | 0.018 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.584510e-01 | 0.018 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 9.586626e-01 | 0.018 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.586626e-01 | 0.018 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.586626e-01 | 0.018 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.586626e-01 | 0.018 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.594276e-01 | 0.018 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.598617e-01 | 0.018 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.598703e-01 | 0.018 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.620770e-01 | 0.017 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.622462e-01 | 0.017 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.622462e-01 | 0.017 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.622462e-01 | 0.017 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.626640e-01 | 0.017 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 9.652096e-01 | 0.015 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.652096e-01 | 0.015 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.654035e-01 | 0.015 | 1 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.654444e-01 | 0.015 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.658537e-01 | 0.015 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.673295e-01 | 0.014 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.680835e-01 | 0.014 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.698968e-01 | 0.013 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.707202e-01 | 0.013 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.707202e-01 | 0.013 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.707202e-01 | 0.013 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 9.722634e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.731393e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.731393e-01 | 0.012 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.731393e-01 | 0.012 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.735818e-01 | 0.012 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.737386e-01 | 0.012 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.745446e-01 | 0.011 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.753586e-01 | 0.011 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.753586e-01 | 0.011 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.755913e-01 | 0.011 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.768982e-01 | 0.010 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.773946e-01 | 0.010 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.773946e-01 | 0.010 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.773946e-01 | 0.010 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.773946e-01 | 0.010 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.783164e-01 | 0.010 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.789247e-01 | 0.009 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.792626e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.792626e-01 | 0.009 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.804215e-01 | 0.009 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.809763e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.818880e-01 | 0.008 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.825484e-01 | 0.008 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.825484e-01 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.825484e-01 | 0.008 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.831120e-01 | 0.007 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.843190e-01 | 0.007 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.843838e-01 | 0.007 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.844617e-01 | 0.007 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.847800e-01 | 0.007 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.853139e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.853139e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.857117e-01 | 0.006 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.861075e-01 | 0.006 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.864317e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.874577e-01 | 0.005 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.876415e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.883609e-01 | 0.005 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.886631e-01 | 0.005 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.886631e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.886631e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.897776e-01 | 0.004 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.909705e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.913801e-01 | 0.004 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.913801e-01 | 0.004 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.913801e-01 | 0.004 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.920062e-01 | 0.003 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.921600e-01 | 0.003 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.926364e-01 | 0.003 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.935931e-01 | 0.003 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.937872e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.938184e-01 | 0.003 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.948076e-01 | 0.002 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.949280e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.949280e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.949280e-01 | 0.002 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.953002e-01 | 0.002 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.956133e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.956133e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.957288e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.963091e-01 | 0.002 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.966145e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.969280e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.969556e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.971516e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.973873e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.976092e-01 | 0.001 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.978018e-01 | 0.001 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.979838e-01 | 0.001 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.981318e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.984441e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.985729e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.986304e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.987457e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.987995e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.987995e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.987995e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.989153e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.989311e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.990619e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992069e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.992810e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994486e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.995486e-01 | 0.000 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.996625e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996735e-01 | 0.000 | 1 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.996917e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997151e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.997458e-01 | 0.000 | 1 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.997787e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.998079e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.998279e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998485e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998619e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999125e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999241e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999431e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999431e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999563e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999604e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999832e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999850e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999855e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999874e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999902e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999923e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999927e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999927e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999959e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999970e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999970e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999972e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999986e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999995e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999996e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999996e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999997e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.000000e+00 | 0.000 | 1 | 1 |
| CREB phosphorylation | R-HSA-199920 | 1.000000e+00 | 0.000 | 1 | 1 |